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Abstract 
Electrokinetic Chromatography using Novel Unilamellar Vesicles for Unique Separations 
and Prediction of Intestinal Permeability 
Stephanie Ann Schuster 
Dr. Joe P. Foley 
 
 
 
Using synthetic unilamellar vesicles as the pseudostationary phase in electrokinetic 
chromatography has several advantages.  These types of vesicles are easy to prepare, 
inexpensive, and are similar in structure to cell membranes.  The research presented in 
Chapter 2 explores the effect of changing the counterion of the cationic surfactant 
component of the vesicles from bromide to chloride.  In addition, the effect of adding 
acetonitrile and 2-amino-1-butanol is investigated for both types of vesicles.  Linear free 
energy relationship (LFER) analysis is performed on the vesicles in order to quantify the 
intermolecular interactions that are responsible for retention.  The results indicate that 
there are unique selectivity differences between using cetyltrimethylammonium bromide 
(CTAB)/sodium n-octyl sulfate (SOS) and cetyltrimethylammonium chloride 
(CTAC)/SOS vesicles. 
 
Chapter 3 investigates the potential of using a partially fluorinated vesicle by combining 
CTAB with sodium perfluorooctanoate (FC7).  The goal was to identify vesicles with 
smaller mean diameters in order to increase the sensitivity of the analysis.  In addition, 
the effect of the fluorinated surfactant on selectivity was determined along with LFER 
analysis in order to compare to the CTAB/SOS vesicles.  The resulting CTAB/FC7 
vesicles were smaller than the CTAB/SOS vesicles and the CTAC/SOS vesicles.  The 
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CTAB/FC7 vesicles, however, were difficult to work with in terms of their reproducibility 
and unstable baseline at short wavelengths. 
 
In Chapter 4 are presented the correlations of Caco-2 permeability and intestinal 
permeability with retention factor measured by CTAB/SOS vesicles and CTAC/SOS 
vesicles for 22 pharmaceutical compounds.  The results were promising in terms of the 
neutral and cationic analytes.  However, there was difficulty in correlating the retention 
factors of the anionic compounds to both the Caco-2 and the intestinal permeabilities due 
to problems in being able to accurately calculate retention factor.  In addition, the 
logarithm of the octanol-water partition coefficient for each compound was also 
correlated to the logarithm of the retention factors. 
 
This research has proven that two new unilamellar vesicle systems (CTAC/SOS and 
CTAB/FC7) are viable as pseudostationary phases for use in electrokinetic 
chromatography.  Furthermore, there were promising results in terms advancing VEKC 
as a high throughput method for screening intestinal permeability. 
 
 
 
 1
Chapter 1:  Introduction to Capillary Electrophoresis 
 
 
 
1.1 Historical Background of Capillary Electrophoresis (CE) 
Capillary electrophoresis (CE) is a powerful analytical technique that was developed by 
Hjerten in 1967 [1].  Electrophoretic methods of analysis were in existence before that 
time, though.  Hjerten’s research advisor, Tiselius, was a pioneer in the use of 
electrophoresis to investigate proteins and was awarded the Nobel Prize in 1948 for his 
work [2].  After Hjerten’s landmark discovery that using 300 µm tubes for 
electrophoresis would decrease thermal effects and that detection of the compounds could 
be done using UV absorbance, other researchers continued to develop the technique [2].  
The next breakthrough discovery came when Jorgenson and Lukacs published results 
using capillaries with internal diameters of less than 100 µm [3, 4].  This led to enhanced 
interest in CE and a steady increase in publications per year for about two decades [5]. 
 
1.1.1 Components of CE Instrumentation 
The basic components of CE include a polyimide-coated fused silica capillary, a high 
voltage power supply, two buffer reservoirs that can hold the capillary and the electrodes, 
and a detector [6].  See Figure 1.1 for a schematic of CE instrumental components.  The 
inner diameter of the capillary can vary from 2 to 100 µm, while the range of the power 
supply is typically from 0 to 60 kV with most commercial instruments operating at a 
maximum of 30 kV.  The detector could be a UV detector (single, variable wavelength 
can be collected), a photo diode array (PDA) detector (entire spectrum can be collected), 
a laser induced fluorescence detector, electrochemical detector, or a mass spectrometer. 
  
 
 
Figure 1.1.  Schematic of CE instrumental components [6].   
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1.1.2 Modes of CE and Fundamental Theory of CE 
 
The modes of CE are the different types of CE that are commonly employed by analysts.  
The different modes are capillary zone electrophoresis (CZE) or free solution CE 
(FSCE), micellar electrokinetic chromatography (MEKC), capillary isoelectric focusing 
(CIEF), capillary gel electrophoresis (CGE), capillary isotachophoresis (CITP), and 
capillary electrochromatography (CEC) [7].  The basic theory behind each of these 
modes of CE can be simplified to the theory behind CZE, which is the least complicated.  
To begin a CZE separation, a fused silica capillary is first activated with a concentrated 
solution of aqueous hydroxide.  Then it is rinsed with water and filled with a buffer [8].  
Next, sample is introduced to the inlet end of the capillary using either hydrodynamic or 
electrokinetic injection.  The ends of the capillary and platinum electrodes are placed in 
vials filled with buffer.  Then voltage is applied to the system.  The charged analytes in 
the sample plug each move according to their individual electrophoretic mobilities [6].  
The analytes eventually move past a detector where the data is collected and stored by a 
data acquisition system [6].   
 
The CE separation is governed by the mobility of the analytes.  The net mobility of an 
analyte is given by the following equation:  
    epeonet µµµ +=    (1.1) 
where µeo (electroosmotic mobility) and µep (electrophoretic mobility) are given by the 
following equations [9]: 
    
dl
eo πη
εζµ
4
=     (1.2) 
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where ε is the permittivity of the buffer, ζ is the zeta potential, and ηdl is the viscosity in 
the electrical double layer. 
η
ζεεµ arep 03
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⎛=     (1.3) 
where ε0 is the permittivity of a vacuum, εr is the relative permittivity of the buffer (εr = 
εbuffer/4π ε0), ζa is the zeta potential of the analyte, and η is the viscosity of the buffer.  It 
should be pointed out the neutral molecules have no electrophoretic mobility.  Normally, 
Equations 1.2 and 1.3 are not used to calculate µeo and µep, respectively.  It is more 
practical to use the following equation for µeo: 
    
0
det
Vt
LL tot
eo =µ     (1.4) 
where Ldet is the length of the capillary to the detector, Ltot is the total length of the 
capillary, and V is the total applied voltage, and t0 is the migration time of a neutral 
analyte.  
The practical equation for µep is as follows: 
R
Reo
ep t
tt )( 0 −= µµ    (1.5) 
where tR is the migration time of the analyte. 
 
For traditional CZE using a positive applied voltage at the capillary inlet, the migration 
order is cations, neutrals, and then anions.  Cations and anions can be separated from 
each other, but neutral compounds elute in one peak.  See Figure 1.2 for a typical CZE 
separation.  Since neutrals have no electrophoretic mobility, they co-migrate with the 
same velocity as the EOF, reaching the detector window at the same time. 
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Figure 1.2.  Typical CZE separation [6]. 
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Electroosmotic flow (EOF) is the pumping mechanism behind CE.  EOF is generated at 
the interface of the capillary wall and the buffer solution when voltage is applied.  The 
resulting electric double layer is shown in Figure 1.3.  Above pH 2 cations adsorb to the 
negatively charged ionized silanol groups that compose the wall of the capillary to form 
the inner Helmholtz plane (IHP) or Stern layer [10].  A diffuse layer of solvated cations 
and anions make up the outer Helmholtz plane (OHP) or Gouy-Chapman layer.  In the 
presence of an electric field, the solvated cations migrate to the cathode and bring solvent 
with them [10].  The movement of the solvated cations is what creates EOF. 
 
The motion of the solvated cations that generates EOF occurs in several steps.  First, as 
the cations in the diffuse layer migrate toward the cathode, they bring with them the 
water molecules that are solvating them.  Next, the water molecules on the cations drag 
other water molecules that are solvating the rest of the components in the capillary, 
including anions and neutrals, through friction.  This frictional drag occurs all the way 
across the internal diameter of the capillary.  The fluid filling the capillary begins to 
move almost all at the same velocity, which gives the flat flow profile characteristic of 
electrophoretic techniques.   
 
EOF is affected by several factors, including buffer pH and concentration, temperature, 
viscosity, field strength, and organic modifiers [7].  Buffer pH affects the zeta potential in 
Eq. 1.2.  EOF is faster at high pH compared to low pH due to the fully ionized silanols 
[7].  Since there are more SiO- groups, more cations adsorb to the surface, creating a 
dense electrical double layer [7].  Figure 1.4 illustrates the effect of pH on EOF using 
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Figure 1.3. A. Dimensions of a typical capillary used for CE. B. Electrical double layer 
inside a capillary. [6]. 
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Figure 1.4.  Effect of pH on EOF using Pyrex, silica, and Teflon capillaries[11]. 
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three different types of capillaries:  Pyrex, silica, and Teflon.  Silica capillaries have the 
biggest range of EOF over the pH range of 3 to 8 out of the three capillary types. 
 
Buffer concentration or ionic strength influences EOF.  With increasing ionic strength, 
EOF decreases.  See Figure 1.5 for an example.  The ionic strength controls the zeta 
potential, which is in the numerator of Eq. 1.2.  Zeta potential is defined as the potential 
at the plane of shear and is proportional to the amount of charge on the surface of the 
silica multiplied by the counterion layer thickness [12] or electrical double layer.  The 
amount of charge on the surface is reduced due to the presence of more counterions with 
increasing ionic strength [13].  In addition, higher ionic strength compresses the electrical 
double layer [13].  Since the two parameters that are proportional to zeta potential are 
reduced, the zeta potential, and hence, EOF are reduced. 
 
EOF is also affected by temperature because temperature affects the viscosity of the 
buffer.  Remember that viscosity is in the denominator of Eq. 1.2.  When temperature 
increases, the viscosity decreases which increases EOF.  With increased field strength, 
the EOF also increases.  Adding organic solvents to the buffer affects the buffer viscosity 
and the zeta potential, depending on the identity of the organic solvent [7].  Short chain 
alcohols, such as methanol and ethanol, usually decrease the EOF by increasing the 
viscosity [7].  
 
Controlling EOF is essential to obtaining reproducible results in CE.  There are both 
chemical and physical methods for controlling EOF.  Chemical methods rely on i)  
 10
 
 
 
 
 
Figure 1.5.  Effect of ionic strength on EOF.  A box = phosphate; circle = borate; triangle 
= carbonate [14]. 
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surface-coating methods that bind polymers or nonionic surfactants to the surface silanols 
or ii) changing the chemical composition of the background electrolyte by varying the pH 
and ionic strength or adding organic solvents or surfactants [10].  A surfactant that is 
often used to reverse the direction of EOF is cetyltrimethylammonium bromide (CTAB).  
The physical methods for controlling EOF make use of a radial electric potential gradient 
to directly control the zeta potential and therefore EOF [10]. 
 
Temperature control in CE also plays a crucial part in obtaining reproducible, highly 
efficient peaks.  Commercially available CE instruments offer either air cooled or liquid 
cooled thermostatting systems.  Joule heating is caused by the movement of ions relative 
to neutral solvent molecules in an electric field.  To reduce Joule heating, one can either 
decrease the cross-sectional area of the capillary or lower the current [6].  The preferred 
method is to reduce the current by using a lower applied voltage or a separation buffer 
with a lower ionic strength [6].  Of these two options, using a lower applied voltage 
would increase the total run time whereas using a lower strength separation buffer would 
not.  Also, using a lower separation strength buffer could potentially mean an increase in 
EOF and then a decrease in resolution. 
 
In order to separate neutral compounds, Terabe et al. [15] performed electrophoretic 
separations with sodium dodecyl sulfates (SDS) micelles included in the background 
electrolyte (BGE).  This is called Micellar Electrokinetic Chromatography (MEKC).  
Analytes partition into and out of the micelles during the separation.  If the analyte is 
more hydrophobic, it will spend a greater amount of time associated with the micellar 
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phase than the BGE phase.  The micelles act similarly to the stationary phase (SP) in high 
performance liquid chromatography (HPLC), but they are not fixed inside the capillary.  
Hence the term pseudostationary phase (PSP) is used to describe the micelles [16].  PSPs 
today are not limited to micelles alone.  Other PSPs that have been used include vesicles 
[17], microemulsions [18], cyclodextrins [19], polymers [20], and surfactant coated 
carbon nanotubes [21].  With this in mind, the broad term electrokinetic chromatography 
(EKC) is used and then the PSP is specified as the first one or two letters as in vesicle 
EKC (VEKC) and microemulsion EKC (MEEKC).   
 
There are three modes of EKC:  normal, reversed, and restricted [22].  In normal mode, 
the electroosmotic velocity and the velocity of the PSP have the same direction, but the 
electroosmotic velocity is greater than the PSP velocity.  In both reversed mode and 
restricted mode, the electroosmotic velocity and the velocity of the PSP have the opposite 
direction.  In addition, the electroosmotic velocity is lower than the PSP velocity.  
Reversed mode and restricted mode have the potential for long analysis times [22].  Since 
the PSPs used in the research described here were negatively charged, the experiments 
were restricted to normal mode EKC. 
 
In EKC, the PSP is typically charged and has an effective electrophoretic mobility [23].  
The PSP will eventually move past the detection window.  The usual elution order of the 
analytes in normal mode, when a positive voltage is applied to the inlet of the capillary, is 
the neutral EOF marker (t0), cations, neutrals, anions, and then the marker for the PSP 
(tpsp).  For a typical MEKC separation, see Figure 1.6.  The ratio of tpsp/t0 is called the  
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Figure 1.6. Typical MEKC separation [24]. 
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migration window [25] or elution range.  All of the neutral molecules must elute in the 
time span between t0 and tpsp in order to be separated in normal mode [23].  Proper 
maintenance of pH is essential to maintaining the expected elution order.  Figure 1.7 
illustrates an example of the effect of pH on elution order.  In Figure 1.7 A, the buffer pH 
was 7.2 and the elution was phenol followed by methyl benzoate.  However, the elution 
order reversed when the buffer pH increased to 10.6.  In Figure 1.7 B the methyl 
benzoate elutes first followed by the phenol.  Since the pH was now higher than the pKa 
of phenol (9.89) [26], phenol was converted from its neutral state to a predominantly 
anionic state (via ionization of the hydroxyl group) and thus eluted after the neutral 
methyl benzoate.   
 
The retention factor (k) is the ratio of the number of moles of solute in the micellar phase 
to the number of moles of solute in the aqueous buffer phase.  Since it is not realistic to 
count the moles of solute in either phase, an equivalent calculation using retention time 
has been derived.  In MEKC k is given by [27]: 
  
⎟⎟⎠
⎞
⎜⎜⎝
⎛ −
−=
R
r
R
t
tt
ttk
10
0    (1.6) 
where tmc is the migration time of the micelle.  Eq. 1.6 is only valid for neutral solutes.  k 
can also be written in terms of mobility and is applicable for both neutral and charged 
solutes [28]: 
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Figure 1.7.  Elution order reversal for phenol (1) and methyl benzoate (2) using 
unmodified CTAC/SOS vesicles (A) and 0.5 % 2-amino-1-butanol modified CTAC/SOS 
vesicles (B).  A 10 mM HEPES buffer at pH 7.2 was used for the unmodified vesicles 
and a 10 mM HEPES buffer at pH 10.6 was used for the 2-amino-1-butanol modified 
vesicles.  Separation conditions:  A new fused silica capillary of 31.2 cm total length, 
20.0 cm length to the detector, 50 µm ID, and 363 µm OD at 25°C was used for each 
vesicle system.  An applied voltage of 14 kV was used and injection was done 
hydrodynamically for 4.0 s at 13.8 mbar (0.2 psi).  Detection was done using PDA at 214 
nm. 
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where µep,ves , the electrophoretic mobility of the vesicle pseudostationary phase, is found 
by subtracting the electroosmotic mobility (µeo) from the net mobility of the vesicle 
(µves), i.e., µves-µeo.  The relative electrophoretic mobility (µr) is the ratio of µep,analyte/µeo.  
 
Chromatographic column efficiency in MEKC has to do with the random movement of 
the solute as it alternates between interacting with the stationary phase (micelles) and 
being carried along by the mobile phase (BGE).  The random movement prevents all of 
the solute molecules from reaching the detector at the same time, which causes the signal 
to appear as a symmetrical peak with width instead of a delta function (spike).  The 
amount of broadening of the signal peak is caused by the broadening of the injection plug 
band as it moves through the capillary [29].  Efficiency can be measured by two related 
terms, which are plate height (H) and number of theoretical plates (N).  These are related 
by the following equation: 
  
H
LN =     (1.8) 
where L is the length of the capillary.  Given this simple equation, it should not be 
difficult to solve for either H or N, provided the other two variables are known.  
However, H and N are theoretical concepts, not physical parameters that can be easily 
measured.  In addition, the plate theory has been replaced by the rate theory, which still 
uses the terms N and H [29].  Today H is defined as: 
  
L
H
2σ=     (1.9) 
where σ2 is the variance (standard deviation squared) of the peak measurement.  
Mathematically, the variance of the peak can be determined and there are several 
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variations of the formula to calculate N, depending on how and where the peak width is 
measured.  This group’s preferred method of calculating N is to use the Foley-Dorsey 
equation [30]: 
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where tR is the migration time, W0.1 is the peak width at 10% peak height, and a0.1 and b0.1 
are the respective widths of the first and second halves of the peak at 10% peak height.  
Figure 1.8 shows a diagram of the specific measurements of the peak. 
 
Compared to the efficiencies observed in HPLC, the efficiencies observed in EKC are far 
superior [22]  Conventional HPLC efficiencies are 15,000 compared to 200,000 in EKC 
[22].  Part of the reason for the drastic difference is the difference in the flow profiles of 
the two techniques.  HPLC with hydrodynamic or pressure-driven flow has a parabolic 
profile while EOF has a flat plug-like profile.  See Figure 1.9.  Pressure-driven flow has a 
leading edge that contributes to the broader peaks that are observed in HPLC.  With EOF, 
there is no leading edge so the analyte molecules reach the detector at virtually the same 
time.   
Resolution (Rs) can be calculated using the following equation, which is valid for neutral 
solutes and charged enantiomers [28]: 
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Figure 1.8. Diagram of the specific measurements of a peak where tR is the migration 
time of the analyte, A is the width at 10% of the first half of the peak, and B is the width 
at 10% of the second half of the peak.  The total width at 10% peak height (W) is given 
by A+B [30]. 
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Figure 1.9.  Comparison of a.) Laminar or hydrodynamic flow profile to b.) 
electroosmotic flow profile [31]. 
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where α = k2/k1 is the chromatographic selectivity, k1 and k2 are the retention factors of 
the first and second analytes, respectively, kavg is the average retention factor, and tpsp is 
the time that it takes the pseudostationary phase to migrate to the detector.  All other 
symbols have been previously defined.   
 
Peak capacity is the maximum number of analytes that can be separated in a single run 
[32].  In the normal mode of EKC, the migration window limits both the peak capacity 
and the maximum achievable resolution.  The last term in Eq. 1.11 has the ratio t0/tpsp.  
Even with a value of infinity for tpsp, the maximum value of resolution in normal mode 
EKC would be much less than conventional HPLC for the same values of efficiency, 
selectivity, and retention factor.  Fortunately, the extremely high efficiencies that are 
obtained in EKC offset the limitation of the migration window [22].   
 
1.1.2.1    Introduction to and Brief Review of Vesicle Electrokinetic 
Chromatography (VEKC) 
 
Numerous papers have been published on the characterization of vesicles using EKC, 
however, for the purposes of this review, only papers where the vesicles were used as a 
pseudostationary phase have been included.  What are vesicles and/or what are they 
comprised of?  Vesicles are a type of surfactant aggregate that consist of one or more 
concentric bilayers surrounding an aqueous core.  They can be composed of natural or 
synthetic surfactants.  Figure 1.10 has the structures of the surfactants that were 
investigated in this thesis.  Liposomes are vesicles that are composed of phospholipids.  
Vesicles are larger than micelles and can either be unilamellar or multilamellar, 
depending on the processing method [33]. 
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Figure 1.10. Structures of the surfactant components of the vesicles in this thesis. 
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Figure 1.11 shows a comparison of a micelle versus unilamellar and multilamellar 
vesicles.   
 
In Table 1.1 is a comprehensive list of all the vesicles and liposomes that have been used 
as pseudostationary phases for EKC.  Vesicle electrokinetic chromatography (VEKC) 
was first reported by Zhang et al. in 1995 [34].  They used liposomes composed of L-α- 
phosphatidylcholine and sodium cholate to separate peptides and four drugs.  This initial 
report was followed by two papers published in 1996.  The first was published by Roberts 
et al. [35] and focused mainly on the characterization of liposomes using CE.  They were 
able to calculate the concentration of the liposomes, as well as the uniformity of the size 
distribution.  Additionally, at the end of their paper, they included the electropherograms 
of riboflavin with and without liposomes.  When riboflavin was analyzed in the presence 
of liposomes, the migration time of riboflavin increased from 9.7 min. to 13.5 min.  This 
proved that there was an interaction between riboflavin and the liposomes.  The second 
report was published as a Letter to the Editor in Analytical Sciences by Nakamura et al. 
[36].  They described the use of liposomes formed from dimyristoyl L-α-
phosphatidylcholine (DMPC) and dimyristoyl L-α-phosphatidyl-D,L-glycerol (DMPG)  
for the separation of i) naphthalene and biphenyl and ii) nitrobenzene and three positional 
isomers of dinitrobenzene. 
 
1.1.2.1.1 Early VEKC 
From the late 1990’s to the present, various groups have used vesicles as a 
pseudostationary phase.  The interest in this area of research has prompted the publication 
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Figure 1.11. Structure and size of a micelle compared to a unilamellar vesicle and a 
multilamellar vesicle.  SUV = small unilamellar vesicle; LUV = large unilamellar vesicle; 
MUV[sic] = multilamellar vesicle [33]. 
 
 24
Table 1.1 Components of vesicles that have been used for VEKC. 
 
Composition Modifier Reference(s) 
L-α-phosphatidylcholine (PC) and cholate None [34] 
Dimyristoyl L-α-phosphatidylcholine (DMPC) 
and dimyristoyl L-α-phosphatidyl-D,L-glycerol 
(DMPG) 
None [36] 
DMPG, dicetyl phosphate, 1,1’-dioctadecyl-
3,3,3’,3’-tetramethylindodicarbocyanine, and 
cholesterol 
None [35] 
N-dodecyltrimethylammonium bromide and 
sodium dodecyl sulfate (SDS) None [17] 
Bis (2-ethylhexyl) sodium sulfosuccinate (AOT) None [37] 
Cetyltrimethylammonium bromide (CTAB) and 
dodecoxycarbonylvaline (DDCV) None [38] 
1,2-dipalmitoyl-sn-glycero-3-phosphocholine 
(DPPC), 1-palmitoyl-2-oleyl-sn-glycero-3-
phosphocholine (POPC), egg yolk 
phosphatidylglycerol (PG), cardiolipin, 
phosphatidic acid ( PA), and bovine brain 
phosphatidylserine (PS) 
None [39] 
Dihexadecyl hydrogen phosphate None [40, 41] 
CTAB and sodium n-octyl sulfate (SOS) None [42] 
PC, PG, cardiolipin, PA, and PS  None [43] 
Dipalmitoyl-L-a-phosphatidylcholine, 
dipalmitoyl-L-a-phosphatidylglycerol, and 
cholesterol 
None [44] 
CTAB and SOS; AOT None [45] 
CTAB and SOS 
 
Glycidol, 1,3-
butanediol, 2-
amino-1-
butanol, 1,2,6-
hexanetriol and 
ACN 
[46] 
POPC and cholesterol None [47] 
Dihexadecyldimethylammonium bromide None [48] 
POPC or POPC with different proportions of 
bovine brain PS  Cholesterol  [49] 
Commercial cationic liposome formulations, 
Lipofectamine and Escort, None [50] 
Sodium N-[4-dodecyloxybenzoyl]-L-valinate None [51] 
CTAB and SOS; octyltrimethylammonium 
bromide (OTAB) and SDS; AOT, POPC and PS None [52, 53] 
POPC None [54, 55] 
(1R,2S)-(−)-N-dodecyl-N-methyl-ephedrinium 
bromide None [56] 
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Table 1.1  (continued)   
1-palmitoyl-2-oleyl-sn-glycero-3-
phosphatidylcholine and PS  None [57] 
PC; DPPC Calcium, 
Magnesium, 
and Zinc 
[58] 
PC, PS, PG, 1,2-dipalmitoyl-sn-glycero-3-
phosphoethanolamine (PE), L-α-
phosphatidylinositol (PI), and sphingomyelin, 
(SPH) 
Cholesterol [59] 
PC and PG Cholesterol  [60] 
PC and PS None [61, 62] 
Sodium N-(4-n-dodecyloxybenzoyl)-l-valinate None [63] 
POPC and PS  [64] 
CTAB and SOS; Cetyltrimethylammonium 
chloride (CTAC) and SOS 
2-amino-1-
butanol; ACN [65] 
1-palmitoyl-2-oleyl-sn-glycero-3-
phosphatidylcholine, PC, and PS Cholesterol  [66] 
Dipalmitoylphosphatidylcholine, SPH, and 
human red blood cell ghost lipids  Cholesterol  [67] 
Sodium N-[4-n-dodecyloxybenzoyl]-L-leucinate 
(SDLL) and sodium N-[4-n-
dodecyloxybenzoyl]-L-isoleucinate (SDLIL) 
None [68] 
PC vesicles in the presence of 20 mol% PS, PA, 
PI, and PG  
Cholesterol; 
Calcium 
chloride  
[69] 
PA, PG, PI, PS, and POPC None [70] 
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of two reviews [33, 71].  In the early stages of VEKC, Hong et al. [17] reported the first 
use of synthetic vesicles as a pseudostationary phase (PSP).  Some of the major findings 
of this study were improvements in efficiency, selectivity, and elution range compared to 
using micelles as the PSP.  Following this report using synthetic vesicles was one that 
included surfactant vesicles composed of CTAB and the chiral surfactant DDCV [38].  
However, in spite of an increased elution range and selectivity improvements, no chiral 
separations were reported.  Another report investigated vesicles formed from bis(2-
ethylhexyl)sodium sulfosuccinate (AOT) which were used in the separation of 
antioxidants that are commonly found in food [37].  Another early use of liposomes in 
EKC was published by Wiedmer et al. [39].  This group used several different 
combinations of phospholipids for their study which investigated the effect of buffer, 
concentration, cardiolipin (CL) concentration, and polar head group for the separation of 
six corticosteroids.  By increasing the amount of negative charge on the liposomes and by 
increasing the total lipid concentration, the separations improved [39]. 
 
1.1.2.1.2 Use of VEKC to Determine Partition Coefficients 
There have been several reports using VEKC to determine various partitioning 
coefficients (K).  In chromatography, K is ratio of the concentration of the analyte in the 
stationary phase to the concentration of the analyte in the mobile phase [29].  In EKC, the 
stationary phase is usually a surfactant aggregate and the mobile phase is the BGE.  The 
earliest report from Agbodjan et al. investigated solute partitioning into dihexadecyl 
hydrogen phosphate (DHP) vesicles [40].  Here they used the Linear Solvation Energy 
Relationship (LSER) model to characterize the solute-vesicle interactions.  The LSER 
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model is useful for determining the types of intermolecular interactions that contribute to 
partitioning.  This is possible due to the relationship between retention factor (k) and the 
partition coefficient (K) as shown in the following equation [44]: 
    [ ]( CACPvK
V
VKk lw
aq
l
lw −∗=⎟⎟⎠
⎞
⎜⎜⎝
⎛= )   (1.12) 
where Klw is the liposome-water partition coefficient, Vl is the volume of the liposomes, 
Vaq is the volume of the aqueous phase, v  is the partial specific molar [sic] volume of the 
phospholipid, [P] is the phospholipid concentration, and CAC is the critical aggregation 
concentration.  From the LSER model, they learned that solute size and hydrogen bond 
acceptor strength contributed the most to partitioning. 
 
Other researchers have attempted to correlate retention factors with octanol-water 
partition coefficients (Kow) [42, 45] with the goal of developing a rapid alternative to the 
shake-flask method.  Vesicle-water partition coefficients were determined for 41 
uncharged solutes using DHP vesicles at both 36 °C and 71 °C [41] .  Liposome-water 
partition coefficients were studied by Burns et al. [72] using liposomes composed of 
dipalmitoyl-L-α-phosphatidylcholine , dipalmitoyl-L-α-phosphatidylglycerol (sodium 
salt), and cholesterol.  Similarly, partitioning into cationic vesicles of 
dihexadecyldimethylammonium bromide was investigated [48].  LSER analysis was used 
to supplement the study.  In addition, LSER analysis has been reported for vesicle 
analysis by other researchers [44, 52].  The main conclusion from the LSER analysis has 
been that the factors that contribute the most to retention are the size and hydrogen bond 
basicity of the solute. 
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1.1.2.1.3 Traditional Separations using VEKC 
There are a limited number of traditional separations using VEKC.  Hong et al. 
investigated the separation of substituted benzenes and geometrical isomers of 
nitrotoluene [17].  One example used POPC/PS liposomes to separate benzene 
derivatives, steroids, and phenols while adjusting the pH and the salt concentration [43].  
Another example used 1-palmitoyl-2-oleyl-sn-glycero-3-phosphocholine (POPC) for the 
analysis of basic proteins [54, 55] and peptides [54].  They obtained nearly baseline 
separation of cytochrome c, lysozyme, ribonuclease A, and α-chymotrypsinogen using 60 
µM POPC suspension in 20 mM phosphate buffer, pH 7.4, containing 68 mM NaCl. 
 
1.1.2.1.4 Chiral Analysis using VEKC 
Chiral separations using VEKC were first reported in 2003 by Mohanty and Dey [51].  In 
this work, Mohanty and Dey utilized vesicles composed of sodium N-[4-
dodecyloxybenzoyl]-L-valinate (SDLV) for the separation of (±)-1,1’-bi-2-naphthol and 
(±)-1,1’-binapthyl-2,2’-diylhydrogenphosphate.  They continued to explore the 
possibility of using VEKC to conduct chiral analyses of nonsteroidal anti-inflammatory 
drugs [56].  Additional work was conducted to determine the interaction of the chiral 
SDLV vesicles with five sterically hindered atropisomeric compounds, such as 
(±)binaphthyl diamine, and benzoin (BZN) [63].  Two more types of chiral vesicles 
formed from sodium N-[4-n-dodecyloxybenzoyl]-L-leucinate (SDLL) and sodium N-[4-
n-dodecyloxybenzoyl]-L-isoleucinate (SDLIL) were also described to test the role of the 
surfactant headgroup for the chiral separations of atropisomeric compounds [68]. 
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1.1.2.1.5 Modifiers in VEKC 
In terms of modifying the environment of the vesicles, two different methods have been 
employed i) the addition of cholesterol and ii) the addition of organic modifiers.  
Wiedmer et al. included cholesterol in their liposome solutions in order to better model 
real biological membranes [47].  Depending on the identity of the buffer that was used, 
the cholesterol-containing liposomes were larger (AMPSO; DIPSO; HEPES) or smaller 
(MOPS; Tricine) than the liposomes without cholesterol.  Also, as the concentration of 
cholesterol increased, the interaction between the liposomes and estradiol decreased.  
Pascoe and Foley were the first to use organic modifiers with VEKC to investigate 
potential enhancements to the separations [46].  They used CTAB/SOS vesicles with five 
different organic modifiers and included LSER analysis to describe the interactions that 
were responsible for retention.  A subsequent project investigating organic modifiers is 
reported in Chapter 2 of this thesis [65].  The research in Chapter 2 also considers the 
effect of changing the cationic counterion from bromide to chloride.  One of the 
significant findings of this work was the improvement in efficiency observed for 
hexanophenone and heptanophenone using vesicles modified with 10% ACN. 
 
1.1.2.1.6 Liposome Capillary Coatings  
Several papers have been published on the use of liposomes for coating capillaries for 
EKC.  The liposomes form a bilayer coating on the surface of the capillary as a stationary 
phase [49].  Hence, separation of neutral compounds is possible and has been 
demonstrated [49].  Some of the parameters that have been investigated regarding 
liposome coatings have been the addition of calcium [57], the effect of pH [61], and the 
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effect of piperazine buffers [66].  Calcium improved the stability of the coatings.  In an 
attempt to increase the rigidity of the membrane, other divalent metals such as 
magnesium and zinc were investigated [58], along with the effect of temperature.  Just as 
cholesterol was added to the free liposomes, it was also added to those for capillary 
coatings [67].  The presence of cholesterol improved the stability of the DPPC coating at 
45 °C, but had no effect on the DPPC coating stability at 25 °C.  In addition, red blood 
cell ghost lipids were used as a capillary coating [67].  Unfortunately, the stability of the 
red blood cell ghost lipid coating changed with time over the course of 18 runs of five 
neutral steroids.  The stability of the phospholipid coatings was examined via 
asymmetrical flow field-flow fractionation and CE [69].  Most recently, the importance 
of the phospholipid polar head group for coatings on silica has been examined [70].  
Liposomes with 1-palmitoyl-2-oleyl-sn-glycero-3-phosphatidylcholine (POPC) and one 
of the following: phosphatidic acid (PA), phosphatidylglycerol (PG), phosphatidylinositol 
(PI), or phosphatidylserine (PS), as well as 3 mM of CaCl2 were included in the study.  
Calcium was shown to interact the most strongly with POPC membranes that contained 
PA. 
 
1.1.2.1.7 Drug-vesicle Partitioning and Drug Delivery via Vesicles 
Finally, there has been interest in studying drug-vesicle interactions using VEKC.  
Manetto et al. studied the interaction of POPC with salicylic acid, acetylsalicylic acid, 
ketoprofen, phenytoin and propranolol [73].  Their results indicated that acidic and 
neutral compounds could be analyzed together, but basic compounds needed to be 
analyzed separately.  Carrozzino and Khaledi also examined the interactions between 
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drugs and lipids, but with regard to buffer type, concentration, ionic strength, and 
liposome composition [59].  Of these, ionic strength and increased charge on the 
liposomes were more influential than buffer type and concentration.  They continued 
their studies by investigating the effect of pH on the drug-liposome interactions [60].  
The study concluded that with increasing pH, the retention of basic drugs decreases 
sigmoidally when they interact with negatively charged liposomes [60].  Yet another 
example of drug membrane permeability correlated with VEKC data has been given by 
Oernskov et al. who correlated retention factor data to two parameters that estimate 
intestinal absorption:  the distribution coefficient in octanol/water for charged compounds 
at a given pH (Log D) and Caco-2 permeability [64].  Pascoe et al. also correlated 
retention factor data from VEKC to intestinal permeability [53].  The correlations were 
strong and proved that intestinal permeability could be modeled using VEKC.  Very 
recently, Wang et al. attempted to correlate retention factors from liposome EKC to the 
fraction of the drug absorbed in humans (Fa) {Wang, 2007 #189}.  Their results showed 
a sigmoidal relationship between the logarithm of the retention factor and Fa.  Related to 
the study of drug-liposome interactions is the delivery of drugs via liposomes.  There is 
one example of such work by McKeon and Khaledi who used laser-induced fluorescence 
to monitor the delivery of antisense oligonucleotide [50].  In this work, they were able to 
calculate the binding constants for the oligonucleotide with two commercially available 
liposomes, Lipofectamine and Escort. 
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1.2 Background of Linear Free Energy Relationship (LFER) Analysis  
LFER analysis was developed in order to quantify the intermolecular interactions that are 
responsible for retention.  Presented here is a brief introduction to LFER.  For a 
comprehensive discussion of LFER, please see the 2006 review by Vitha and Carr [74].  
Although LFER was first reported in 1921 [75], it was Hammett’s research [76, 77] that 
brought attention to the subject.  Kamlet et al. introduced LFER analysis using the 
solvatochromic model in 1983 [78], which is described by the following equation: 
    αβπ absVmkk ++++=
100
loglog 0   (1.13) 
where k is the retention factor, log k0 is a regression constant, and the coefficients m, s, b, 
and a are the cohesiveness, dipolarity, hydrogen-bond donor ability, and hydrogen-bond 
acceptor ability of the applied surfactant system.  V is the molar volume of the solute, π is 
a measure of the solute dipolarity/polarizability, β is the hydrogen-bond acceptor 
ability, and α is the hydrogen bond donor ability of the solute [79].  The solvatochromic 
model was later modified by Abraham [80] who added a sixth parameter and called his 
model the solvation model.  One advantage of the solvation model over the 
solvatochromic model is the use of free-energy related solute properties over 
spectroscopic energies [81].  Also, one can easily determine more solute descriptors, 
whereas there is no set method of determining other solvatochromic “solute” parameters 
[81].  The following equation is used to describe most of the contributing factors to 
solute-solvent interactions: 
log k = c + vV + eE + sS + aA + bB     (1.14) 
where k is the retention factor, V, E, S, A, and B are the solute descriptors, c is the y-
intercept, and v, e, s, a,  and b are the system coefficients.  Among the solute descriptors, 
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V is the McGowan’s characteristic volume, which can be calculated [82].  Provided the 
structure of the compound is known, there is a simple formula for calculating McGowan's 
characteristic volume by taking the sum of the atomic volumes minus the value of each 
bond (6.56 cm3mol-1), where all bonds are treated equally no matter if they are single, 
double, or triple bonds [83].  E represents excess molar refraction and can be calculated 
using the refractive index of the solute at 20°C for the sodium D-line [81].  Next S 
represents dipolarity/polarizability, which is determined from liquid-liquid distribution 
constants and chromatographic measurements [83].  A and B represent hydrogen bond 
acidity and hydrogen bond basicity, respectively.  Both A and B are determined in a 
similar fashion to S.  The system coefficient v is the difference in the ease of cavity 
formation for the solute between the buffer and the aggregate phase, e is the difference in 
capacity of the buffer and the aggregate phase to interact with the solutes’ n- or π- 
electrons, s is the difference in dipolarity/polarizability between the aggregate phase and 
the bulk aqueous phase, a is the difference in hydrogen bond basicity, and b is the 
difference in hydrogen bond acidity.  The system coefficients are calculated using 
multiple linear regression on a highly overdetermined data set, i.e., a data set in which the 
number of retention factor measurements (of different solutes) greatly exceeds the 
number of system coefficients and y-intercept in Eq. 1.14.   
Once the system coefficients are obtained, then they are evaluated based upon their 
magnitude, chemical meaning, and signs [74].  The magnitude of the coefficient 
corresponds to the difference between the interactions of the two phases under study and 
the amount each interaction contributes to retention [74].  The chemical meaning of the 
coefficients is that they are “complementary to the solute parameter which they modify” 
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[74].  For example, the coefficient b represents differences in solvent hydrogen bond 
acidity and modifies B which is the solute’s hydrogen bond basicity descriptor [74].  
Depending on how the solute property is defined, the sign of the coefficient signifies 
“which phase has a greater interaction ability for each specific interaction being 
modeled” [74].  In the LFER results presented in this work, the solute property is 
retention so the differences are between retention by the pseudostationary phase 
(vesicles) versus the BGE.  Negative values indicate that the BGE has more interactions 
of a specific type than the vesicle phase.  The number of solutes required for the LFER 
analysis is between 20 and 40 [83].  However, the solutes must comprise a wide range of 
interactions.  This requirement can be tested through the use of cross-correlation analysis.  
If the correlation coefficient is ≥ 0.8 (r2 > 0.64), then the group of solutes chosen must be 
reconsidered [83].   
 
Abraham based his solvation parameter model on a cavity model of solution [83].  Figure 
1.12 shows the steps of solvation.  Initially, an appropriately sized cavity is formed in the 
solvent for the solute [83].  This process requires an amount of energy dependent upon 
the intermolecular forces holding the solvent together and the size of the solute [83].  
Next, the solvent molecules gather around the solute to reestablish equilibrium, a process 
that requires minimal energy [83].  Lastly, the solute enters the cavity and begins to 
interact with the solvent molecules surrounding it [83].  For a neutral analyte, the forces 
could be dispersion, induction, orientation, and hydrogen bonding [83].  The free energy 
of transfer that occurs in electrokinetic chromatography is equal to “the difference in  
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Figure 1.12. Steps of solvation [74]. 
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cavity formation and solute-solvent interactions in the electrolyte solution and 
pseudostationary phase” [83]. 
 
Once the LFER coefficients have been obtained, they are usually compared to other sets 
of coefficients.  There have been a few different methods for LFER coefficient 
comparison [84-86].  The most recent approach normalizes each coefficient by dividing 
by a normalization factor (ω) [87].  Taking the coefficient e as an example: 
    ω
eeu =      (1.15) 
where the subscript u indicates the normalized coefficient and ω is given by: 
ω = e2 + s2 + a2 + b2 + v2    (1.16) 
Then, the normalized coefficients are used to calculate a distance (d) using the following 
equation [88]: 
( ) ( ) ( ) ( ) ( )22222 ujuiujuiujuiujuiujui vvbbaasseed −+−+−+−+−=  (1.17) 
If the value of d is < 0.25, then the two systems are considered similar [88].  One of the 
most significant aspects of these comparisons is that all types of separation systems may 
be compared to each other.  The LFER coefficients do not have to be taken from EKC 
data, but they could be from HPLC or GC, as well. 
 
Overall, LFER analysis is a powerful tool for investigating the intermolecular interactions 
that contribute to retention/partitioning.  Much invaluable information can be obtained by 
using LFER analysis.  This easy method has applicability to several different systems, 
such as MEKC, HPLC, GC, and SFC, which makes it truly impressive [74].   
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Chapter 2:  Effect of Surfactant Counterion and Organic Modifier on the Properties 
of Surfactant Vesicles in Electrokinetic Chromatography 
 
2.1 Introduction 
Drug delivery devices, cell membrane models, and pseudostationary phases (PSPs) in 
EKC are some of the most beneficial applications of vesicles.  Targeted drug delivery is 
made possible by vesicles [1, 2].  Also, vesicles are a less expensive, lower maintenance 
alternative to using in-vivo cell cultures, such as Caco-2, to investigate cell membrane 
permeability [3, 4].  Finally, compared to micelles, vesicles offer unique separation 
mechanisms and increased elution ranges as PSPs in EKC. 
 
Nakamura et al. reported the first separation using L-α-phosphatidylcholine/L-α-
phosphatidyl-D,L-glycerol liposomes in CE in 1996 [5] and coined the phrase “liposome 
electrokinetic chromatography.”  Also in 1996, Roberts et al. [6] showed that the 
electropherogram of riboflavin was altered in the presence of liposomes.  Then Hong et 
al. described the first use of synthetic DTAB/SDS vesicles in EKC [7].  They reported 
improvements in efficiency, selectivity, and elution range over conventional SDS 
micelles.  Following those events, papers detailing other applications of vesicles in EKC 
other than pure separations began to emerge including the determination of octanol-water 
partition coefficients [8, 9], and vesicle-water partition coefficients [10].  Separations 
using vesicles have also been reported [11-14] with one of the most recent being 
enantiomeric separations using chiral vesicles reported by Mohanty and Dey [15, 16]. 
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There have been numerous reports on the effect of counterions on micelles in EKC [17-
23], but no reports on the effect of counterions on vesicles in EKC.  Results of a 
comparison of counterion effects on vesicles not within the context of EKC have revealed 
that tosylate counterions yield larger diameter vesicles compared to bromide counterions 
with a cetyltrimethylammonium surfactant/dodecylbenzene sulfonic acid vesicle system 
[24]. 
 
Organic modifier effects in CE have long been studied by a variety of researchers and 
have been reviewed [25, 26].  Among the motivations that Huie cites for groups using 
organic modifiers in the BGE are increased solubility of hydrophobic compounds, 
improved selectivity, ability to use higher applied voltages resulting in decreased run 
times, and making the CE to MS interface more compatible.  Additionally,  organic 
solvents have been used in field-amplified sample stacking  to lower the conductivity of 
the BGE [27].  Another advantage is decreased retention, which has been demonstrated 
by Ahmed and Lloyd [28].  Decreased retention also results in decreased run times, and 
also in improved resolution for compounds whose retention is greater than the optimum 
value.  Organic modifiers have been divided into Class I and Class II materials [29].  
Class I modifiers are incorporated into the surfactant aggregate and Class II modifiers 
affect the solvent-aggregate interactions.  Examples of Class I modifiers include long-
chain amides and alcohols.  Examples of Class II modifiers include short-chain alcohols, 
formamide, acetonitrile (ACN), guanidinium salts, and urea. 
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While there have been several reports regarding the effect of organic modifiers on 
micelles [30-34], there have not been nearly as many reports regarding the effect of 
organic modifiers on polymeric PSPs and vesicles.  The effect of adding methanol and 
acetonitrile to anionic siloxane surfactants was investigated by Peterson et al. [35].  Their 
results showed that the siloxanes’ electrophoretic mobilities remained high in the 
presence of the organic solvents, the methylene selectivities were also high, and the 
elution range was large.  In addition, they demonstrated the nearly complete baseline 
separation of 14 PAHs in the presence of 40% ACN.  In 2002, Pascoe and Foley [36] 
described the effect of Class I and Class II modifiers on CTAB/SOS vesicles.  Their 
findings included the fact that (i) increasing the percentage of ACN increased the elution 
range; and (ii) 2-amino-1-butanol (AB) had the least dramatic effect on methylene 
selectivity.  Therefore, these two modifiers were chosen for the present study. 
 
The experiments described here include the first report of CTAC/SOS vesicles as a PSP 
in EKC.  Both unmodified CTAC/SOS and CTAB/SOS vesicles are compared to AB 
modified vesicles and ACN modified vesicles of the same types.  Electrophoretic and 
chromatographic parameters are provided for all six vesicle systems studied.  Despite the 
mixed results concerning the effect of organic modifier on efficiency in MEKC [19, 37-
39], significant increases in efficiency were observed for the more hydrophobic 
alkylphenones in the presence of 10% ACN vs. unmodified vesicles for both CTAB/SOS 
and CTAC/SOS.  LFER analysis has also been included to aid in the quantification of 
specific molecular interactions. 
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2.2 Materials and Methods 
2.2.1 Chemicals and Reagents 
 
SOS was purchased from Lancaster Synthesis Inc. (Windham, NH, USA).  CTAB, 
CTAC, HEPES, 2-amino-1-butanol, and all of the solutes used in LFER analysis were 
purchased from Sigma-Aldrich (St. Louis, MO, USA).  HPLC grade methanol and HPLC 
grade acetonitrile were purchased from Fisher (Fairlawn, NJ, USA).  Water from a 
Barnstead E-pure Water system (Dubuque, IA, USA) was used to prepare the buffer. 
2.2.2 Instrumentation 
 
All separations were performed on a Beckman Coulter P/ACE™ MDQ Series Capillary 
Electrophoresis System (Fullerton, CA, USA) equipped with a diode array detector.  
Wavelengths of 214 and 246 nm were collected.  The temperature was set at 25°C for 
both the capillary cartridge and the compartment that holds both the sample and buffer 
solutions.  An applied voltage of 14 kV was used for all separations so that Joule heating 
would not exceed 1.5 W/m; in addition, a linear voltage ramp (0.17 min.) from 0 to 14 
kV was employed during the application of the applied voltage to prevent accidental 
sample loss due to thermal expansion caused by Joule heating.  The samples were 
injected for 2.0 seconds at 13.8 mbar (0.2 psi).  The data were collected and processed 
using Beckman Coulter 32 Karat™ Software Version 5.0 (Fullerton, CA, USA). 
 
The size of the vesicles was measured using a Horiba LB 500 Dynamic Light Scattering 
Particle Size Analyzer (Irvine, CA, USA) while the temperature was maintained at 25°C. 
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A new 31.2 cm x 50 µm ID fused silica capillary from Polymicro Technologies (Phoenix, 
AZ, USA) was used for each vesicle system investigated.  Prior to first use, each capillary 
was conditioned for 5 min with HPLC-grade water, 10 min with 1.0 M sodium 
hydroxide, 5 min with 0.1 M sodium hydroxide, 3 min with HPLC-grade water, and 15 
min with background electrolyte (BGE), all at an applied pressure of 2070 mbar (30 psi).  
Between injections the capillary was rinsed with BGE for 2 min at 2070 mbar. 
2.2.3 Vesicle Preparation 
 
All of the vesicle systems were prepared in a 1:3.66 mole ratio of CTAB:SOS or 
CTAC:SOS for a total surfactant concentration of 69 mM.  The mole ratio and total 
surfactant concentration was optimized in earlier work [40, 41].  First CTAB was 
dissolved in a beaker in a small amount of water and an appropriate amount of stock 
HEPES buffer adjusted to pH 7.2 by 1.0 M LiOH.  The solution was stirred and heated on 
a low setting until all of the CTAB dissolved.  Next the heat was turned off and the SOS 
was stirred into the still warm CTAB solution with more water until it dissolved.  The 
resulting solution appeared bluish, was transferred to a volumetric flask, and was vortex 
mixed for approximately 2 minutes.  The vesicles were allowed to equilibrate for a 
minimum of 12 hours before use.  The same procedure was used to prepare CTAC/SOS 
vesicles.  For the Class I modified vesicles, 0.5 % (v/v) of AB was added to a volumetric 
flask and then the surfactant solution (CTAB or CTAC and SOS) was added to the flask.  
For the Class II modified vesicles, 10 % (v/v) ACN was added similarly.  The 
concentrations of AB and ACN were chosen based upon previous work by Pascoe and 
Foley [36].  However, organic modifier was added into the beaker initially [36], whereas 
it was added to the volumetric flask in the present study.  Prior to use, the vesicles were 
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filtered using a 0.45 µm nylon membrane filter (13 mm diameter) from Whatman 
(Clifton, NJ, USA). 
 
2.2.4 Sample Preparation 
Stock solutions ranging from 3-6 mg/mL were prepared for all solutes by dissolution of 
the appropriate amount in HPLC grade methanol.  The stock solutions were then diluted 
with 10 mM aqueous HEPES buffer at pH 7.2 (7 parts stock + 3 parts buffer). 
Since the conductivity of the final sample was somewhat lower than that of the BGE, a 
slight amount of field-amplified zone sharpening occurred for the sample zone. 
 
2.2.5 Calculations 
All of the migration times were corrected for the 0.17 min voltage-ramp that was used 
according to the following equation: 
  
2
ramp
rVRC
t
tt −=      (2.1) 
where tVRC is the voltage-ramp corrected migration time, tr is the migration time of the 
solute, and tramp is the time of the linear voltage-ramp (10.2 s). 
The maximum of the first positive baseline disturbance caused by methanol at 214 nm 
was used as the t0 marker.  This value was used in the following equation to calculate 
electroosmotic mobility (EOF):  
Vt
LL td
eo
0
=µ       (2.2) 
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where Ld is the length of the capillary to the detector, Lt is the total length of the 
capillary, t0 is the time of an neutral marker, and V is the applied voltage. 
The retention factors of the solutes were calculated using the following equation: 
r
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where µep,ves , the electrophoretic mobility of the vesicle pseudostationary phase, is found 
by subtracting the electroosmotic mobility (µeo) from the net mobility of the vesicle 
(µves), i.e., µves-µeo.  The net (observed) vesicle mobility, µves, is calculated via Eq. (2.2), 
with the migration time of the vesicle (tves) substituted for t0.  Finally, the relative 
electrophoretic mobility (µr) is the ratio of µep,analyte/µeo. 
A homologous series of alkylphenones (acetophenone through heptanophenone) were 
analyzed and their retention factors calculated in order to determine tves, using the method 
of Bushey and Jorgenson [42] in which the logarithm of the retention factor vs. carbon 
number of a homologous series is assumed to yield a linear relationship.  The retention 
time of heptanophenone is used as a starting value for tves.  Then multiple iterations are 
performed to maximize r2 to determine tves [36]. 
Polar group selectivity is defined here as the quotient of the retention factor of a 
substituted benzene (ks) divided by the retention factor of benzene (kb): 
b
s
PG k
k=α       (2.4) 
As αPG approaches unity, the resolution of benzene and the substituted benzene in 
question approaches zero.  Similarly, as the αPG’s for two benzene derivatives approach 
the same value, the resolution for those compounds also approaches zero.  
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Efficiency was calculated using the Foley-Dorsey equation [43]: 
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where tr is the migration time, W0.1 is the peak width at 10% peak height, and a0.1 and b0.1 
are the respective widths of the first and second halves of the peak at 10% peak height. 
 
The change in retention factor with respect to the change in ACN content was calculated 
using the equation below: 
  %100*%
mod
modmod
un
un
k
kkChange −=   (2.6) 
 
where kmod is the retention factor of the solute using the 10% ACN modified vesicles and 
kunmod is the retention factor of the solute using the unmodified vesicles. 
 
The LFER coefficients were normalized by dividing each coefficient by the following 
normalization parameter [44]: 
  22222 vbase ++++=ϖ     (2.7) 
 
2.3 Results and Discussion 
2.3.1 Vesicle Size Comparison 
Prior to size measurement, the vesicles were filtered using 0.45 µm nylon filters.  The 
mean diameter of each vesicle system was then measured three times and the averages 
are presented in Table 2.1.  Unmodified CTAB/SOS had a smaller mean diameter than 
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Table 2.1.  Effect of counterion and organic modifier on mean diameter and 
electrophoretic parameters. 
 
Vesicle 
Systema)
Mean 
Diameter 
(nm) 
EOFb)
µeo  
(x 10-4 cm2/Vs) 
Electrophoretic 
mobilityb)
µep 
 (x 10-4 cm2/Vs) 
Elution Range 
(tves/to) 
Unmodified 
CTAB/SOS 85 ± 6 4.17 -3.72 9.32 ±0.19 
0.5 % v/v 
2-amino-1-
butanol 
modified 
CTAB/SOS 
105 ± 10 4.02 -3.52 8.06 ± 0.12 
10% v/v 
Acetonitrile 
modified 
CTAB/SOS 
111 ± 3 3.27 -2.80 7.04 ±0.10 
Unmodified 
CTAC/SOS 96 ± 3 4.28 -3.79 8.22 ± 0.06 
0.5 % v/v 
2-amino-1-
butanol 
modified 
CTAC/SOS 
74 ± 4 3.97 -3.44 7.38 ±0.12 
10% v/v 
Acetonitrile 
modified 
CTAC/SOS 
83 ± 3 3.35 -2.80 6.05 ± 0.12 
 
a) All vesicle systems are in a 1:3.66 mole ratio CTAB or CTAC to SOS in a 10 mM 
HEPES buffer at pH 7.2. 
b) The uncertainties in the EOF and electrophoretic mobility were all less than 7 x 
10-6 cm2/Vs. 
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unmodified CTAC/SOS vesicles.  However, the opposite was observed for the 
corresponding modified vesicles.  For both the AB modified and 10% ACN modified 
vesicles, the CTAB/SOS vesicles were larger than the CTAC/SOS vesicles.  For the AB 
modified vesicles, the mean diameter of CTAB/SOS vesicles increased by 24% whereas 
the mean diameter of the CTAC/SOS vesicles decreased by 23%.  For the 10% ACN 
case, the mean diameter of the CTAB/SOS vesicles increased by approximately 30% 
whereas the mean diameter of the CTAC/SOS vesicles decreased by approximately 14%.  
The presence of organic modifier had an overall larger effect on the CTAB/SOS vesicles.  
These size results are somewhat different from the results of Pascoe and Foley [36].  In 
particular, no difference in mean diameter of CTAB/SOS vesicles was reported for the 
addition of AB, nor 10% ACN.  The disagreement among the results can be attributed to 
a difference in the way the vesicles were prepared, specifically the time when the organic 
modifier was added during the vesicle preparation.  In this work, the organic modifier 
was added after vesicle formation occurred, contrary to that of the previous work.  This 
may also account for other differences between the research results, including LFER 
coefficients. 
 
2.3.2  Electrophoretic Parameters 
The electrophoretic parameters were calculated based upon the equations presented in 
Section 2.2.5.  Shown in Table 2.1 are the electrophoretic parameters for the six vesicle 
systems that were investigated. 
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2.3.2.1  Electroosmotic Flow 
Both unmodified vesicle systems showed similar values for EOF (µeo), with the 
CTAB/SOS vesicle system exhibiting a 3% lower EOF.  For the AB modified vesicles, 
the EOFs were also very similar.  The extent to which EOF decreased in the presence of 
AB was 4% for the CTAB/SOS vesicles and 8% for the CTAC/SOS vesicles.  EOF was 
affected the most by the presence of acetonitrile.  There was a 22% decrease in EOF for 
both the CTAB/SOS vesicles and the CTAC/SOS vesicles in the presence of 10% ACN.  
The ACN-mediated decrease in EOF is due to an increase in the viscosity of the bulk 
aqueous phase and a decrease in the zeta potential of the capillary [45], the potential at 
the shear plane within the electrical double layer.   
The trend in the EOF values that was observed going from unmodified vesicles to 
modified vesicles regardless of counterion was that the presence of organic modifier 
decreased EOF.  Pascoe et al. [36] reported similar results, although a somewhat smaller 
reduction in EOF was observed in the presence of 10% ACN.   
 
2.3.2.2  Electrophoretic Mobility of the Vesicles (µep,ves) 
Table 2.1 reports the electrophoretic mobility of the vesicles.  The electrophoretic 
mobilities of the unmodified vesicles are statistically the same, which was not expected 
due to the differences in the mean diameters of the vesicles.  However, the mobilities 
may be similar due to similar average charge densities around the net negative vesicles.  
The vesicles have net negative charges due to the excess SOS that is present in their 
compositions.  Overall, the charge to frictional drag ratio of the vesicles is similar despite 
the identity of the counterion.  
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With the addition of organic modifier, the electrophoretic mobilities of both kinds of 
vesicles decreased, but the magnitude depended on the identity and concentration of the 
modifier.  With 0.5 % AB, the electrophoretic mobilities of CTAB/SOS and CTAC/SOS 
vesicles decreased by 5% and 8%, respectively.  With 10% ACN, the respective 
electrophoretic mobilities decreased by 22% and 26%. From these results, it seems that 
both organic modifiers have a slightly smaller effect on the electrophoretic mobility of 
CTAB/SOS vesicles than they do on CTAC/SOS vesicles. 
 
2.3.2.3  Elution Range 
As shown in Table 2.1, the largest elution range of all six vesicle systems studied was 
found for the unmodified CTAB/SOS vesicles.  The elution ranges of the unmodified 
vesicles were consistently higher than the organic modified vesicles.  This indicates that 
EOF is not decreasing as rapidly as µep,ves for the organic modified vesicle systems.  AB, 
which is positively charged at pH 7.2, could interact with the negatively charged vesicles.  
Based on the molar ratios of AB to vesicles, there could be 1.12 x 105 AB molecules 
associated with a single vesicle at a given time.  This would lower the net charge of the 
vesicle (and possibly increase its frictional drag), thereby decreasing its electrophoretic 
mobility.  ACN, which interacts more with the bulk phase than the vesicle aggregates, 
has been shown to slightly reduce EOF [46] compared to small chain alcohol organic 
modifiers.  Since the viscosity of a water-10 % acetonitrile mixture is slightly higher than 
the viscosity of water alone [47], the electrophoretic mobility of the vesicles decreased.  
In these results, the effect of increased viscosity on the electrophoretic mobility is greater 
than the effect on EOF.  The local viscosity of the electrical double layer can increase due 
 58
to adsorption of solvent molecules at the interface of the capillary wall and the electrolyte 
solution [48].  The adsorption, described by Schwer and Kenndler [45], would lead to a 
reduction in EOF caused by the displacement of hydroxide ions by the solvent molecules.  
Since electrophoretic mobility is decreasing faster than EOF, it may be that the viscosity 
of the bulk solution is slightly higher than that of the electrical double layer, depending 
upon the number of solvent molecules adsorbed to the surface.  Since acetonitrile 
interacts through dipole forces, which are weaker than hydrogen-bonding forces, it could 
be likely that not many acetonitrile molecules are present near the capillary wall, thus 
unable to contribute to a higher local viscosity in the electrical double layer.  The most 
significant change in elution range was exhibited by the 10% ACN modified vesicles 
compared to the unmodified vesicles.  
 
2.3.3  Polar Group Selectivity 
Table 2.2 presents the polar group selectivities of eight substituted benzenes for the 
vesicle systems investigated.  For the unmodified CTAB/SOS vesicles, the polar group 
selectivity of phenol was close to unity, which means it would not be resolved from 
benzene.  Similarly, the selectivity of phenol was also close to unity for the unmodified 
CTAC/SOS vesicles and would probably not be well resolved from benzene.  For the AB 
modified CTAC/SOS vesicles, nitrobenzene rather than phenol (with unmodified 
CTAB/SOS vesicles) had a polar group selectivity close to unity.  Further comparisons 
within a given vesicle system showed that (i) aniline and benzaldehyde had nearly 
identical polar group selectivities in unmodified CTAB/SOS vesicle 
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Substituted 
Benzenes 
Unmodified 
CTAB/SOS 
0.5 % v/v 2-
amino-1-
butanol 
modified 
CTAB/SOS 
10% v/v 
Acetonitrile 
modified 
CTAB/SOS 
Unmodified 
CTAC/SOS 
0.5 % v/v 2-
amino-1-
butanol 
modified 
CTAC/SOS 
10% v/v 
Acetonitrile 
modified 
CTAC/SOS 
Benzyl alcohol 0.18 ± 0.001 0.20 ± 0.005 0.12 ± 0.001 0.19 ± 0.001 0.21 ± 0.002 0.18 ± 0.001 
Aniline 0.30 ± 0.001 0.30 ± 0.001 0.17 ± 0.003 0.28 ± 0.004 0.31 ± 0.003 0.25 ± 0.002 
Acetophenone 0.32 ± 0.003 0.35 ± 0.002 0.35 ± 0.002 0.34 ± 0.001 0.38 ± 0.001 0.30 ± 0.001 
Benzaldehyde 0.31 ± 0.002 0.57 ± 0.003 0.27 ± 0.02 0.31 ± 0.003 0.29± 0.002 0.32 ± 0.002 
Nitrobenzene 0.90 ± 0.003 0.90 ± 0.002 0.47 ± 0.007 0.85 ± 0.01 1.01 ± 0.04 0.75 ± 0.005 
Phenol 0.98 ± 0.006 1.34 ± 0.01 0.62 ± 0.003 0.94 ± 0.01 1.65 ± 0.0  4 0.76 ± 0.02 
Chlorobenzene 5.43 ± 0.02 4.82 ± 0.01 3.94 ± 0.03 4.73 ± 0.2 6.76 ± 0.08 4.28 ± 0.08 
Bromobenzene 8.17 ± 0.2 6.29 ± 0.09 6.58 ± 0.06 7.49 ± 0.2 10.20 ± 0.2 8.08 ± 0.2 
 
 
 
 
Table 2.2. Comparison of the polar group selectivity of the vesicle systems investigated. 
a) Conditions as in Table 2.1. 
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solutions, while (ii) acetophenone and benzaldehyde and (iii) nitrobenzene and phenol 
had nearly identical or identical values in 10% ACN modified CTAC/SOS, meaning 
that none of these pairs of compounds would be resolved from each other; the results 
suggest that the presence of a non-hydrogen bonding molecular dipole like ACN may 
result in reduced differences in other types of intermolecular interactions, a minor 
disadvantage that is compensated by other beneficial effects discussed in later 
sections.    
The fact that the polar group selectivity several of the compounds is significantly 
different among the six vesicle systems with different counterions or Class I or II 
modifiers means that both counterions and modifiers have a rather profound effect on 
selectivity in vesicle EKC.  
 
2.3.4  Hydrophobic (Methylene) Selectivity 
Hydrophobic selectivity is a measure of the ability of the pseudostationary phase to 
resolve compounds that differ by one or more methylene groups.  This is measured by 
the antilogarithm of the slope of a graph of log k vs. carbon number for a homologous 
series of compounds.  In this study, alkylphenones from acetophenone to 
heptanophenone were used.  Presented in Table 2.3 are the hydrophobic selectivities 
that were observed.  No significant differences were observed between the 
unmodified or ACN-modified pairs of vesicles.  The addition of AB decreased the 
methylene selectivity for the CTAB/SOS vesicles, but had no observable effect on the 
CTAC/SOS vesicles.  The decrease in methylene selectivity for the CTAB/SOS 
vesicles can be attributed to the insertion of the 2-amino-1-butanol into the vesicles, 
which creates a more hydrophilic environment [36].  It is unclear why the 2-amino-1-
butanol had no effect on the methylene selectivity of the CTAC/SOS vesicles. 
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Table 2.3. Comparison of methylene selectivity and efficiency. 
 
Vesicle Systema)
Methylene 
Selectivity 
αCH2
 
Efficiencya) 
N/m 
Efficiencyb) 
N/m 
Unmodified 
CTAB/SOS 3.06 ± 0.003 82,000 14,000 
0.5 % v/v 
2-amino-1-
butanol modified 
CTAB/SOS 
2.93 ± 0.04 95,000 16,000 
10% v/v 
Acetonitrile 
modified 
CTAB/SOS 
2.75 ± 0.05 107,000 140,000 
Unmodified 
CTAC/SOS 3.05 ± 0.02 63,000 11,000 
0.5 % v/v 
2-amino-1-
butanol modified 
CTAC/SOS 
3.06 ± 0.02 31,000 19,000 
10% v/v 
Acetonitrile 
modified 
CTAC/SOS 
2.76 ± 0.02 101,000 140,000 
 
a) Values represent the average of a minimum of 4 results for propiophenone 
(0.66 < k < 1.08 with CTAB/SOS vesicles and 0.66 < k < 1.05 with 
CTAC/SOS vesicles, where k is the retention factor).  The % RSDs of the 
efficiency range from 11 to 33 % for propiophenone. 
b) Values represent the average of a minimum of 4 results for heptanophenone 
(36.5 < k < 91.5 with CTAB/SOS vesicles and 37.7 < k < 88.2 with 
CTAC/SOS vesicles, where k is the retention factor).  The % RSDs of the 
efficiency range from 17 to 24% for heptanophenone. 
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The lowest methylene selectivity was observed for the 10% ACN-modified vesicles, 
and is due to the decrease in the polarity of the bulk aqueous phase resulting from the 
presence of ACN.  Therefore, the difference in polarity between the (polar) bulk 
aqueous phase and the (nonpolar) vesicle aggregates phase is less, which leads to the 
lower methylene selectivities observed. 
 
2.3.5 Efficiency Comparison 
Efficiency (plate count) data for representative hydrophilic and hydrophobic 
compounds, propiophenone and heptanophenone, are also provided in Table 2.3.  
Efficiencies for heptanophenone were very similar for the corresponding unmodified 
and modified CTAB/SOS and CTAC/SOS vesicles, while moderate differences in N 
were observed for propiophenone, giving CTAB/SOS vesicles a slight edge in overall 
separation efficiency.  The most striking feature of this table, however, is the fact that 
the efficiencies for heptanophenone using the 10% ACN modified vesicles increased 
by an average of 91%.  Figure 2.1 shows the electropherogram of unmodified 
CTAC/SOS vesicles compared to the electropherogram of 10% ACN modified 
CTAC/SOS vesicles.  This finding is in contrast to the effect of ACN on the 
efficiency of strongly retained analytes using SDS micelles investigated by Seals and 
Davis [39].  Their work provided evidence that decreased efficiency in SDS BGEs 
with low concentrations of ACN was caused by longitudinal diffusion.  In this 
research, perhaps improved mass transfer in conjunction with reduced retention factor 
leads to the observed increased efficiency.  Heptanophenone’s retention factor (k) was 
reduced from 91.5 to 36.5 when 10% ACN was added to the aqueous CTAB/SOS 
vesicle solution.  Similarly, it decreased from 88.0 to 37.7 when 10% ACN was added 
to the aqueous CTAC/SOS solution. The reduction in k upon the addition of 10% 
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Figure 2.1. Effect of 10% acetonitrile modified CTAC/SOS vesicles on the 
efficiencies of later migrating alkylphenones (B) compared to unmodified CTAC/SOS 
vesicles (A).  A 10 mM HEPES buffer at pH 7.2 was used for both types of vesicles.  
Analytes are a homologous series of alkylphenones from acetophenone to 
heptanophenone.  Separation conditions:  A new fused silica capillary of 31.2 cm total 
length, 20.0 cm length to the detector, 50 µm ID, and 363 µm OD at 25°C was used 
for each vesicle system.  An applied voltage of 14 kV was used and injection was 
done hydrodynamically for 2.0 s at 13.8 mbar (0.2 psi).  Detection was done using 
PDA at 246 nm.   
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ACN was not as dramatic for propiophenone, for which k decreased from 1.08 to 0.66 
and 1.06 to 0.66 in the CTAB/SOS and CTAC/SOS vesicle solutions, respectively.  
Irrespective of the reason(s), the increased efficiency in the presence of ACN 
represents a significant advantage of vesicle EKC over micellar EKC using SDS 
micelles for strongly retained analytes.  With its much higher N and larger elution 
range, VEKC can provide superior resolution for hydrophobic compounds.   
 
2.3.6 Change in Retention Factor (k) with Respect to ACN Content 
Changes in solute retention factors upon the incorporation of 10% ACN into the 
vesicle solutions are presented in Table 2.4 along with the differences between the 
values calculated for CTAB/SOS vesicles and CTAC/SOS vesicles.  Changes in k, 
regardless of counterion, were negative for all compounds except for acetophenone 
using the CTAB/SOS vesicles; the change in k for acetophenone was not statistically 
significant, however.  The results of a t test yielded a value of 2.22, while the ttable 
value at 95 % was 2.447 for 6 degrees of freedom.  The changes were expected to be 
negative since the addition of ACN affects the bulk aqueous phase, making it less 
polar.  This decreased polarity of the bulk aqueous phase caused the compounds to 
spend less time partitioning into the vesicles, which lead to shorter migration times 
and therefore smaller retention factors.  The small % change of 4.2 for acetophenone 
using CTAB/SOS vesicles indicated that using ACN-modified vesicles yielded no 
significant impact for this solute.  The difference between the % changes was negative 
for all but ten solutes, which meant CTAB/SOS had larger % changes in retention 
factor when ACN was added than CTAC/SOS.  This may indicate that ACN had more 
influence on the environment of the CTAB/SOS vesicles than on the environment of 
the CTAC/SOS vesicles. 
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Table 2.4.  Percentage change in solute retention factor upon the incorporation of 10% 
ACN into the specified vesicle solutions.a)
 
 CTAB/SOS vesicles 
CTAC/SOS 
vesicles 
Difference 
∆CTAB/SOS-
∆CTAC/SOS
Aniline -43.0 -28.4 -14.6 
Benzyl alcohol -34.4 -22.7 -11.6 
m-Nitroaniline -65.7 -47.8 -18.0 
Phenol -39.1 -34.2 -4.9 
1-Nitrobutane -16.1 -5.8 -10.3 
Benzaldehyde -16.1 -16.7 0.6 
Benzonitrile -3.8 -21.2 17.4 
Acetophenone 4.2 -29.3 33.5 
Nitrobenzene -49.0 -28.2 -20.8 
p-Cresol -21.8 -33.9 12.1 
m-Cresol -37.7 -34.6 -3.0 
1-Nitropentane -0.8 -2.9 2.2 
Anisole -48.8 -34.8 -14.0 
Methyl benzoate -9.9 -27.7 17.8 
Benzene -2.8 -18.3 15.6 
Propiophenone -4.2 -39.1 34.9 
4-Nitrotoluene -40.5 -25.4 -15.1 
Toluene -46.4 -45.9 -0.4 
Butyrophenone -4.8 -44.4 39.6 
Chlorobenzene -25.5 -26.1 0.6 
Bromobenzene -21.7 -11.9 -9.8 
p-Xylene -39.0 -31.1 -7.8 
Benzophenone -56.2 -28.5 -27.7 
Naphthalene -85.1 -1.8 -83.3 
Biphenyl -74.0 -48.3 -25.7 
Butylbenzene -79.6 -60.7 -18.9 
a) Solutes are listed in order of increasing octanol-water partition 
coefficient (log Pow [49, 50]). 
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Even though both ACN modified vesicle systems had the same electrophoretic 
mobility, the CTAB/SOS vesicles were larger than the CTAC/SOS vesicles. 
 
2.3.7 LFER Analysis 
LFER has been in existence since 1921 [51], but it did not receive much attention 
until the mid to late 1930’s [52, 53].  There are several LFER models, but the one that 
our research group employs was developed by Abraham [54] who based his model on 
modification of the solvatochromic method [55].  Abraham’s solvation model is based 
on the cavity model of solution [56] which was described in Chap. 1.  The following 
equation is used to describe all of the contributing factors to solute-solvent 
interactions: 
log k = c + vV + eE + sS + aA + bB     (2.7) 
where k is the retention factor, V, E, S, A, and B are the solute descriptors, v, e, s, a, 
and b are the system constants, and c is the y-intercept.  Among the solute descriptors, 
V is the McGowan’s characteristic volume and can be calculated [57].  E represents 
excess molar refraction.  It can be calculated using the refractive index of the solute at 
20°C for the sodium D-line [47].  S represents dipolarity/polarizability, and A and B 
represent hydrogen bond acidity and hydrogen bond basicity, respectively.  Shown in 
Table 2.5 are the solute descriptors used for the present study.  After residual analysis 
was performed, three outliers were identified and removed from the solute set.  The 
three outliers were aniline, m-nitroaniline, and butylbenzene.  The cross-correlation 
table for the remaining 23 solutes is shown in Table 2.6.   
 
The system constant v is the difference in the ease of cavity formation for the solute 
between the buffer and the aggregate phase (vesicles), e is the difference in capacity  
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Table 2.5. LFER solutesa) and descriptors [56, 58]. 
 
Solute V E S A B 
Aniline 0.8162 0.955 0.96 0.26 0.50 
Benzyl alcohol 0.9230 0.832 0.95 0.37 0.56 
m-Nitroaniline 0.9904 1.200 1.71 0.40 0.35 
Phenol 0.7751 0.805 0.89 0.60 0.30 
1-Nitrobutane 0.8464 0.227 0.95 0 0.29 
Benzaldehyde 0.8750 0.820 1.00 0 0.39 
Benzonitrile 0.8711 0.742 1.11 0 0.33 
Acetophenone 1.0139 0.818 1.01 0 0.48 
Nitrobenzene 0.8909 0.871 1.11 0 0.28 
p-Cresol 0.9160 0.820 0.87 0.57 0.31 
m-Cresol 0.9160 0.822 0.88 0.57 0.34 
1-Nitropentane 0.9880 0.212 0.95 0 0.29 
Anisole 0.9160 0.708 0.75 0 0.29 
Methyl benzoate 1.0726 0.733 0.85 0 0.46 
Benzene 0.7164 0.610 0.52 0 0.14 
Propiophenone 1.1548 0.804 0.95 0 0.51 
4-Nitrotoluene 1.0320 0.870 1.11 0 0.28 
Toluene 0.8573 0.601 0.52 0 0.14 
Butyrophenone 1.2957 0.797 0.95 0 0.51 
Chlorobenzene 0.8388 0.718 0.65 0 0.07 
Bromobenzene 0.8914 0.882 0.73 0 0.09 
p-Xylene 0.9982 0.613 0.52 0 0.16 
Benzophenone 1.4808 1.447 1.50 0 0.50 
Naphthalene 1.0854 1.340 0.92 0 0.20 
Biphenyl 1.3242 1.360 0.99 0 0.22 
Butylbenzene 1.2800 0.600 0.51 0 0.15 
 
 
a) Solutes are listed in order of increasing octanol-water partition coefficient (log 
Pow [49, 50]). 
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Table 2.6. Cross correlation table of solutes used for LFER Analysis of the 
CTAB/SOS and CTAC/SOS vesicles. 
 
 V E S A B 
V 1.000     
E 0.374 1.000    
S 0.326 0.214 1.000   
A 0.075 0.001 0.000 1.000  
B 0.215 0.021 0.382 0.025 1.000 
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of the buffer and the aggregate phase to interact with the solutes’ n- or π- electrons, s 
is the difference in dipolarity/polarizability between the aggregate phase and the bulk 
aqueous phase, a is the difference in hydrogen bond basicity, and b is the difference in 
hydrogen bond acidity.  The system constants are calculated using multiple linear 
regression. 
 
2.3.7.1  LFER characterization of the vesicle systems 
Table 2.7 lists the results of the LFER analysis of the unmodified and organic 
modified CTAB/SOS vesicles and CTAC/SOS vesicles.  The normalized LFER 
coefficients are shown in Table 2.8.  Closer inspection of the normalized LFER 
coefficients leads to the conclusion that the two vesicle systems are not interacting 
identically in the presence of the organic modifiers.  The two system constants that 
are contributing the most to retention are v and b.  First, consider the system constant 
v, the difference in the ease of cavity formation.  In all cases, the value of normalized 
v is positive, which means it is easier to form a cavity for the solutes in the aggregate 
phase than in the bulk aqueous phase.  For the unmodified vesicles, CTAB/SOS 
vesicles have a slightly lower value of normalized v than CTAC/SOS vesicles, 
indicating that the CTAC/SOS vesicles are very similar in polarity compared to the 
CTAB/SOS vesicles.  This is consistent with the methylene selectivity data in which 
the values were almost identical.  When AB is present, again the values for 
normalized v for both types of vesicles are similar, seeming to indicate that AB has a 
similar effect on the two types of vesicles.  When ACN is present, CTAB/SOS has a 
larger v than CTAC/SOS.  This data seems to suggest that the counterion present does 
not have a large role in determining the extent to which the organic modifier affects 
the vesicles. 
Vesicle 
System Modifier v         e s A b c n r
2 SE F
CTAB/SOS No modifier 
3.32 
(0.07) 
0.59 
(0.04) 
-0.71 
(0.05) 
0.84 
(0.05) 
-3.78 
(0.08) 
-1.72 
(0.05) 23    0.987 0.07 1343
CTAB/SOS 2-Amino-1-butanol 
2.89 
(0.09) 
0.43 
(0.05) 
-0.62 
(0.06) 
0.75 
(0.06) 
-3.17 
(0.10) 
-1.50 
(0.06) 23    0.973 0.09 630
CTAB/SOS 10% Acetonitrile
3.14 
(0.13) 
0.16 
(0.07) 
-0.74 
(0.09) 
0.75 
(0.08) 
-3.11 
(0.15) 
-1.55 
(0.11) 23    0.942 0.13 277
CTAC/SOS No modifier 
3.25 
(0.07) 
0.42 
(0.04) 
-0.78 
(0.05) 
0.83 
(0.04) 
-3.47 
(0.08) 
-1.59 
(0.05) 23    0.987 0.07 1308
CTAC/SOS 2-Amino-1-butanol 
3.18 
(0.11) 
0.43 
(0.06) 
-0.80 
(0.08) 
0.88 
(0.07) 
-3.59 
(0.12) 
-1.45 
(0.08) 23    0.968 0.11 524
CTAC/SOS 10% Acetonitrile
3.00 
(0.07) 
0.38 
(0.04) 
-0.57 
(0.05) 
0.72 
(0.05) 
-3.58 
(0.08) 
-1.61 
(0.05) 23    0.984 0.07 1043
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            Table 2.7. LFER coefficients for CTAB/SOS vesicles and CTAC/SOS vesicles with organic modifiers.a) 
a) Values in parentheses represent standard deviations. 
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Table 2.8. Normalized LFER coefficients for CTAB/SOS vesicles and CTAC/SOS 
vesicles with organic modifiers.a) 
 
Vesicle System Modifier vu eu su au bu
CTAB/SOS No modifier 0.64 (0.02) 
0.11 
(0.01) 
-0.14 
(0.01) 
0.16 
(0.01) 
-0.73 
(0.02) 
CTAB/SOS 
0.5 %  
2-Amino-1-
butanol 
0.65 
(0.02) 
0.10 
(0.01) 
-0.14 
(0.01) 
0.17 
(0.02) 
-0.72 
(0.03) 
CTAB/SOS 10% Acetonitrile 
0.69 
(0.03) 
0.03 
(0.02) 
-0.16 
(0.02) 
0.17 
(0.02) 
-0.69 
(0.04) 
CTAC/SOS No modifier 0.66 (0.02) 
0.09 
(0.01) 
-0.16 
(0.01) 
0.17 
(0.01) 
-0.71 
(0.02) 
CTAC/SOS 
0.5 %  
2-Amino-1-
butanol 
0.64 
(0.03) 
0.09 
(0.01) 
-0.16 
(0.02) 
0.18 
(0.01) 
-0.72 
(0.03) 
CTAC/SOS 10% Acetonitrile 
0.63 
(0.02) 
0.08 
(0.01) 
-0.12 
(0.01) 
0.15 
(0.01) 
-0.75 
(0.02) 
 
a) Values in parentheses represent standard deviations. 
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Next consider normalized b, the difference in hydrogen bond acidity between the 
vesicles and the bulk aqueous phase, for both vesicle systems.  Given the composition 
of the vesicles, the negative values of normalized b, indicating that the bulk aqueous 
phase is a better acid than the vesicles, was expected.  For the CTAB/SOS vesicles, 
the value of b is similar between the unmodified vesicles and both types of organic 
modified vesicles.  The same is true between the unmodified CTAC/SOS vesicles and 
the organic modified CTAC/SOS vesicles.  It is unexpected that the presence of AB 
does not affect b more than the presence of 10% ACN for both vesicle systems.  ACN 
modifies the bulk aqueous phase, whereas AB modifies the vesicles by insertion into 
the bilayer. 
 
Shifting to normalized a, the difference in hydrogen bond basicity between the 
vesicles and the bulk aqueous phase, one notices positive values, which mean that the 
vesicles are able to participate as hydrogen bond acceptors more readily than the bulk 
aqueous phase.  Organic modified CTAB/SOS vesicles leads to the same a value for 
the AB modified CTAB/SOS vesicles and for the ACN modified CTAB/SOS 
vesicles.  Organic modified CTAC/SOS vesicles leads to a similar a value for AB 
modified CTAC/SOS vesicles and a lower a value for ACN modified CTAC/SOS 
vesicles. 
 
An analysis of e, the difference in capacity of the buffer and the aggregate phase to 
interact with the solutes’ n- or π- electrons, reveals a dramatic decrease in normalized 
e for the CTAB/SOS vesicles in the presence of 10% ACN.  Since the e values are 
positive, they signify that the aggregate interacts more than the bulk phase with the 
solutes’ n- or π- electrons.  In the presence of AB, there were similar trends between 
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the CTAB/SOS vesicles and the CTAC/SOS vesicles.  The value of e was identical or 
almost the same for the AB modified CTAC/SOS vesicles and the AB modified 
CTAB/SOS vesicles, respectively. 
 
Finally, an examination of normalized s, the difference in dipolarity/polarizability 
between the aggregate phase and the bulk aqueous phase, shows negative values, 
meaning that the dipolarity/polarizability is greater for the bulk aqueous phase than it 
is for the vesicles.  The CTAC/SOS vesicles have larger s coefficients compared to 
the CTAB/SOS vesicles in all instances except in the presence of 10% ACN.   
 
In summary, the LFER results show distinct differences in the magnitudes of the 
chemical interactions that contribute to retention for the different vesicle systems.  
The most influential coefficients are v and b, which show opposite trends for 
CTAB/SOS vs. CTAC/SOS.   
 
Another way to compare the LFER coefficients is to calculate the d parameter , which 
was introduced in Chap. 1.  If the value of d is greater than 0.25, then the two systems 
can be considered chemically different [59].  The calculated d values are shown in 
Table 2.9.  None of the calculated d values are greater than 0.25, indicating that none 
of the vesicle systems are chemically different from one another. 
 
2.4 Concluding Remarks 
The nature of the counterion for the vesicles studied does not appear to dramatically 
affect the separations of the compounds investigated.  However, even though the 
chromatography is very similar between the unmodified and organic modified   
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      Vesicle System Modifier  1 2 3 4 5 6
CTAB/SOS        No modifier 1 0
CTAB/SOS 0.5 % 2-Amino-1-butanol 2 0.03      0
CTAB/SOS       10% Acetonitrile 3 0.11 0.08 0
CTAC/SOS        No modifier 4 0.05 0.03 0.06 0
CTAC/SOS 0.5 % 2-Amino-1-butanol 5 0.04      0.03 0.08 0.03 0
CTAC/SOS       10% Acetonitrile 6 0.05 0.05 0.11 0.07 0.06 0
 
 
 
 
 
 
 
 
 
Table 2.9. Calculated d values between vesicle systems. 
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CTAB/SOS vesicles and the unmodified and organic modified CTAC/SOS vesicles, 
the mechanism by which these vesicle systems interact with the solutes used for 
LFER analysis is quite different.  In addition, the CTAB/SOS vesicles, whether 
unmodified or modified, had larger elution ranges compared to the CTAC/SOS 
vesicles. 
 
The presence of 10% acetonitrile for both CTAB/SOS vesicles and CTAC/SOS 
vesicles improves the efficiency of heptanophenone, a representative hydrophobic 
compound, by an average of 91%.  The effect of acetonitrile on retention is larger 
using CTAB/SOS vesicles than CTAC/SOS vesicles. 
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Chapter 3:  Fluorinated Vesicles as a Novel Pseudostationary Phase in 
Electrokinetic Chromatography 
 
3.1 Introduction 
Improved sensitivity has been a long-time goal of capillary electrophoresis.  A review 
by Simonet et al. has classified the approaches to meeting this goal into three different 
areas 1) better detectors for CE 2) online capillary pre-concentration methods and 3) 
online coupled flow-injection pre-concentration systems [1].  Some of the detectors 
that have been used for CE in order to improve the sensitivity are mass spectrometry 
(MS) detectors, laser-induced fluorescence (LIF) detectors, and electrochemical 
detectors such as conductivity and amperometric detectors [1].  Each of these has its 
own drawbacks, such as the complications of the CE to MS interface, the need for a 
fluorescently active compound or tag [2], or the difficulty of operation and lack of 
robustness[1]. 
 
Some of the online capillary pre-concentration methods that have been described 
include field-amplified sample stacking (FASS), sweeping, isotachophoresis (ITP), 
and solid-phase extraction (SPE) [1].  Table 3.1 lists some of the online capillary pre-
concentration methods and their corresponding enhancement in sensitivity.  FASS 
involves using a less concentrated buffer for the sample compared to the BGE buffer 
concentration.  The electric field varies according to the local conductivity 
(concentration for a given buffer), and the analytes are focused once they cross the 
boundary between the higher and lower electric field.  FASS is a simple technique 
and can also be used with zones of different pH or viscosity.  One of the only 
disadvantages is the technique’s potential for complicated sample quantitation [1] due  
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Table 3.1. Online capillary pre-concentration methods and their corresponding 
enhancement in sensitivity [3]. 
 
Method Sensitivity Enhancement 
FASS 10-20 
Sweeping 100-5,000 
tITP 100-500,000 
SPE 100-10,000 
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to the possibility of broadened peaks or sample loss from the capillary [4].  Another 
disadvantage is that the use of a BGE with limited conductivity. 
 
Sweeping involves the use of a pseudostationary phase (PSP) in the BGE and the 
absence of that PSP in the sample.  The sample becomes concentrated through the 
extent of its interactions with the PSP, which have been identified as partitioning and 
complexation [5].  With this pre-concentration technique, there are no serious 
difficulties so it may be widely applied, provided the analytes interact to a sufficient 
degree with the PSP that is chosen.   
 
ITP involves the use of a leading electrolyte and a terminating electrolyte, with the 
sample sandwiched in between the two.  The leading electrolyte has a higher mobility, 
and the terminating electrolyte has a lower mobility compared to the sample [6].  In 
CE, transient (t) ITP is typically employed.  When voltage is applied, the components 
of the sample quickly align between the two electrolytes via electrophoretic 
migration; upon alignment all components move toward the detector at the same 
speed.  One aspect that must be considered is the variation of the migration time due 
to differences in sample concentration and composition; an internal standard is 
therefore recommended [6].  Additionally, detection of the analytes has the potential 
to be complicated. 
 
SPE as an online capillary pre-concentration method involves the insertion of a 
microcartridge in the inlet of the capillary [1].  Usually the packing of the 
microcartridge is reversed-phase material, such as C18 coated particles [1].  There are 
two disadvantages of using the SPE technique: 1) the preparation of the 
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microcartridge (difficult); and 2) the short capillary lifetimes when exposed to 
complex sample matrices [1]. 
 
The online coupled flow-injection pre-concentration systems make use of an 
additional instrument coupled to the CE.  These can be interfaced either by a split-
flow interface or a programmable arm.  This approach is useful, but more complex 
due to the additional instrumentation required.  The difference between this technique 
and the one previously described is that SPE is completed separately before the 
sample is injected into the capillary.   
 
We chose an approach to identify and apply smaller vesicles to the EKC methods with 
which we were familiar.  Here we investigated the potential of fluorinated vesicles as 
a PSP in EKC.  Previously, small unilamellar vesicles (SUVs) comprised of 
nonstoichiometric mixtures of oppositely-charged, hydrocarbon surfactants were used 
as PSPs for EKC analysis [7-10].  However, the mean diameters of these vesicles 
ranged from 76 to 110 nm.  Sizes on this order contribute to light scattering, which 
leads to decreased sensitivity with optical detection.  The fluorinated vesicles used in 
these experiments were developed by Iampietro and Kaler at the University of 
Delaware [11].  No other group has reported using vesicles composed of the cationic 
surfactant cetyltrimethylammonium bromide (CTAB) and the anionic surfactant 
sodium perfluorooctanoate (FC7) for use in EKC.  These vesicles were chosen based 
upon their reported mean diameter of 46 nm [12].  This represents a reduction in size 
by almost 50% compared to the CTAB/SOS and CTAC/SOS vesicles previously 
investigated [13].  
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Fluorinated vesicles have been investigated for use as drug carriers [14, 15] and for 
the production of polymerized microcapsules [16].  Vesicles composed of a mixture 
of fluorinated and hydrogenated surfactants display more stability compared to 
vesicles composed of purely hydrogenated surfactants [17].  In addition, 
fluorosurfactants contribute improved resistance to corrosive environments and bio 
fluids [18]. 
 
In addition to the fluorinated vesicles’ smaller size, the interactions between the 
vesicles and the analytes in terms of selectivity was also of interest.  Vesicles with a 
fluorinated component have stiffer bilayers than vesicles with purely hydrocarbon 
components [12].  The stiffness of the fluorinated vesicles’ bilayers could potentially 
contribute to selectivity differences.  Consequently, linear free energy relationship 
(LFER) analysis was utilized to quantitate the interactions responsible for retention. 
 
3.2 Materials and Methods 
3.2.1 Chemicals and Reagents 
CTAB, HEPES, and the solutes used in LFER analysis were purchased from Sigma-
Aldrich (St. Louis, MO, USA).  FC7 was purchased from Alfa Aesar (Ward Hill, MA, 
USA).  HPLC grade methanol was purchased from Fisher (Pittsburgh, PA, USA).  To 
prepare the buffer, water was obtained from a Barnstead E-pure Water system 
(Dubuque, IA, USA). 
 
3.2.2 Instrumentation 
The experiments were performed on a Beckman Coulter P/ACE™ MDQ Series 
Capillary Electrophoresis System (Fullerton, CA, USA) equipped with a diode array 
 
 86
detector.  Data at wavelengths of 214 and 246 nm were collected.  The temperature 
was maintained at 25°C for the capillary cartridge as well as the compartment that 
holds both the sample and buffer solutions.  An applied voltage of 16 kV was used for 
all separations to maintain a Joule heating level of 1.5 W/m or less.  The samples were 
injected for 2 seconds at 13.8 mbar (0.2 psi), corresponding to an injection volume of 
1.5 nL, assuming the viscosity of the buffer is approximately the same as that of water 
at the same temperature.  All data were collected and processed using 32 Karat™ 
Software Version 5.0 by Beckman Coulter. 
 
A Horiba LB 500 Dynamic Light Scattering Particle Size Analyzer (Irvine, CA, USA) 
was used to measure the size of the vesicles.  The temperature was set at 25°C for all 
measurements taken.  Before each sample was analyzed, it was filtered using a 0.45 
µm pore-size nylon membrane filter of 13 mm diameter from Whatman (Clifton, NJ, 
USA).  The average of a minimum of three measurements/sample was reported for 
each batch of vesicles prepared. 
 
A HP 8453 UV-Visible Spectrometer, model number G1103A was used to obtain the 
UV-Visible spectra of the fluorinated vesicles.   
 
A new 31.2 cm x 50 µm ID fused silica capillary from Polymicro Technologies 
(Phoenix, AZ, USA) was used for each preparation of the fluorinated vesicle systems.  
Prior to first use, each capillary was conditioned for 5 min with HPLC-grade water, 
10 min with 1.0 M sodium hydroxide, 5 min with 0.1 M sodium hydroxide, 3 min 
with HPLC-grade water, and 15 min with background electrolyte (BGE) all at an 
applied pressure of 2070 mbar (30 psi).  Between each injection the capillary was 
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rinsed with 0.1 M NaOH for 1 min, HPLC-grade water for 2 min, and BGE for 1.5 
min all at 2070 mbar.  Then 15 kV was applied between the inlet and outlet buffer 
vials for 1.5 min. 
 
3.2.3 Vesicle Preparation 
The fluorinated vesicle system was prepared in a 1:3.3 mole ratio of CTAB:FC7 for a 
total surfactant concentration of 48 mM.  Initially, CTAB was added to a small 
amount of water and an appropriate amount of stock HEPES buffer adjusted to pH 7.2 
by 1.0 M LiOH.  The CTAB solution was stirred and heated on a low setting until all 
of the solid dissolved.  Next the heat was turned off and the FC7 was stirred into the 
still warm CTAB solution. More water was added and the solution was stirred until all 
of the FC7 dissolved.  The resulting solution looked cloudy and was vortex mixed for 
approximately 2 minutes.  The vesicles were allowed to equilibrate for a minimum of 
12 hours before use.  Prior to use, the vesicles were filtered using a 0.45 µm pore-size 
nylon membrane filter of 13 mm diameter from Whatman (Clifton, NJ, USA). 
 
3.2.4 Sample Preparation 
Solutions ranging from 2-8 mg/mL were prepared for all solutes, except biphenyl, 
butyl benzene, and naphthalene, by dissolution of the appropriate amount in a solution 
comprised of 4 mL of aqueous HEPES buffer (10 mM) and 6 mL of HPLC grade 
methanol.  The solvent system for the remaining three solutes consisted 3 mL of 
aqueous HEPES buffer (10 mM) and 7 mL of HPLC grade methanol. 
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3.2.5 Calculations 
The calculations for voltage-ramp corrected migration time, electroosmotic mobility 
(EOF), retention factor, polar group selectivity, and efficiency can be found in 
Chapter 2. 
 
A homologous series of alkylphenones (acetophenone through hexanophenone) were 
analyzed and their retention factors calculated in order to determine tves, using the 
method of Bushey and Jorgenson [19] in which the logarithm of the retention factor 
vs. carbon number of a homologous series is assumed to yield a linear relationship.  
The retention time of hexanophenone is used as a starting value for tves.  Then multiple 
iterations are performed to maximize r2 to determine tves [20]. 
 
3.3 Results and Discussion 
3.3.1 Vesicle Size 
The size of the CTAB/FC7 vesicles compared to the CTAB/SOS vesicles can be 
found in Table 3.2.  The CTAB/FC7 vesicles had a mean diameter of 48 nm, which is 
very close to the mean diameter of 46 nm reported in the literature [12].  It is also 
about half of the size of the CTAB/SOS vesicles.  Thus, one of the goals of the 
investigation (to create smaller vesicles that scatter less light) was met.  Further 
evidence of the smaller size of the fluorinated vesicles was obtained through the 
acquisition of the UV-visible absorption spectra of each type of vesicle.  The buffer is 
the same concentration for both vesicle systems, but the concentration of surfactant 
for the two vesicle systems is different since the vesicles form at different 
concentrations of surfactant.  Figure 3.1 shows the UV-visible absorption spectra of 
CTAB/SOS vesicles compared to CTAB/FC7 vesicles.  The fluorinated vesicles may  
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Table 3.2.  Mean diameter and electrophoretic parameters for CTAB/FC7 and 
CTAB/SOS vesicles. 
 
Vesicle System 
Mean 
Diameter 
(nm) 
EOF 
µeo (x 10-4 
cm2/Vs) 
Electrophoretic 
mobility 
µep (x 10-4 cm2/Vs) 
Elution 
Range 
(tves/to) 
CTAB/FC7 48 ± 4 6.46 -5.22 5.99 ± 0.97 
CTAB/SOS 85 ± 6 3.58 -3.22 10.00 ± 0.22 
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Figure 3.1.  Comparison of UV-visible spectra for A) CTAB/SOS vesicles and B) 
CTAB/FC7 vesicles.  The background for both spectra was 10 mM HEPES buffer pH 
7.2. 
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have been smaller than the CTAB/SOS vesicles because the two types of vesicles are 
stabilized though different processes depending on the value of the bending constant 
K [12].  CTAB/FC7 vesicles are stabilized through spontaneous curvature, which 
means that only one radius is favored energetically [12].  However, CTAB/SOS 
vesicles are stabilized through Helfrich-undulation repulsions, indicating that the 
interbilayer potential is repulsive [12].   
 
3.3.2 Electroosmotic Flow 
For comparison purposes, the corresponding data for CTAB/SOS vesicles as well as 
for CTAB/FC7 vesicles has also been included in Table 3.2.  The EOF using 
CTAB/FC7 vesicles was faster than that observed for the CTAB/SOS vesicles.  Part of 
the reason for this difference is due to the higher voltage at which the CTAB/FC7 
vesicles were analyzed (16 kV vs. 14 kV).  Since the fluorinated vesicles generated 
less current, a higher voltage could be applied while still maintaining a manageable 
level of Joule heating.  Another possible cause for the faster EOF using fluorinated 
vesicles may be that there is less unbound CTAB available to coat the capillary 
surface.  It is well-known that CTAB binds to surface silanols and can reduce, or even 
reverse EOF at sufficiently high concentrations of unbound CTAB [21].  There is a 
higher concentration of CTAB (14.8 mM) in the CTAB/SOS vesicles compared to the 
concentration of CTAB (11.2 mM) in the CTAB/FC7 vesicles so it could be possible 
that unbound CTAB binds to the capillary. 
 
3.3.3 Electrophoretic Mobility of the Vesicles (µep,ves) 
The electrophoretic mobility of the CTAB/FC7 vesicles was higher than that of the 
CTAB/SOS vesicles.  The cause may be attributed to the smaller size of the 
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CTAB/FC7 vesicles.  Since they were smaller, they were able to migrate against EOF 
better than the CTAB/SOS vesicles.   
 
3.3.4 Elution Range 
Although the electrophoretic mobility of the fluorinated vesicles is about 60% higher 
than the CTAB/SOS vesicles, the EOF in the presence of CTAB/FC7 vesicles was 
80% higher, meaning that the fluorinated vesicles had a faster net mobility, which is 
inversely proportional to the elution range (migration window).  Consequently, the 
CTAB/FC7 vesicles had a lower elution range compared to the CTAB/SOS vesicles.   
 
3.3.5 Polar Group Selectivity 
The polar group selectivity of the CTAB/FC7 vesicles and the CTAB/SOS vesicles is 
shown in Table 3.3.  The general trend of the data was that the retention of both polar 
and nonpolar substituted benzenes was reduced relative to benzene using the 
fluorinated vesicles compared to the CTAB/SOS vesicles for all compounds except 
benzaldehyde (statistically equivalent) and acetophenone.  There are some significant 
selectivity differences between the two pseudostationary phases.  First, benzyl alcohol 
and aniline could not be separated by the CTAB/FC7 vesicles, whereas they could be 
separated by the CTAB/SOS vesicles.  Conversely, acetophenone and benzaldehyde 
could be separated by the CTAB/FC7 vesicles, but could not be separated by the 
CTAB/SOS vesicles.   
 
3.3.6 Hydrophobic (Methylene) Selectivity 
Hydrophobic selectivity is a measure of the difference in the hydrophobicity of the 
pseudostationary phase and the bulk electrolyte.  Other chromatographic figures of  
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Table 3.3. Polar Group Selectivity Using CTAB/FC7 Vesicles Compared to 
CTAB/SOS Vesicles 
 
Substituted Benzenes CTAB/FC7 CTAB/SOS 
Benzyl alcohol 0.13 ± 0.04 0.18 ± 0.001 
Aniline 0.13 ± 0.03 0.30 ± 0.001 
Acetophenone 0.42 ± 0.06 0.32 ± 0.01 
Benzaldehyde 0.34 ± 0.06 0.32 ± 0.001 
Nitrobenzene 0.63 ± 0.07 0.90 ± 0.003 
Phenol 0.24 ± 0.07 0.98 ± 0.006 
Chlorobenzene 3.20 ± 0.5 5.43 ± 0.02 
Bromobenzene 4.22 ± 0.3 8.17 ± 0.16 
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merit such as efficiency, retention, and elution range being the same, the greater the 
hydrophobic selectivity, the greater the resolution between compounds that differ 
primarily in hydrophobicity (e.g., homologs).  If the bulk electrolyte is the same (e.g., 
aqueous buffer of specified composition) among the PSPs of interest, then the 
methylene selectivity can be taken as a direct measure of the hydrophobicity of the 
PSP.  The higher the value of the hydrophobic selectivity, the higher the 
hydrophobicity of the pseudostationary phase or the more nonpolar the 
pseudostationary phase is.  The hydrophobic selectivity of the CTAB/FC7 and the 
CTAB/SOS vesicles is given in Table 3.4.  The fluorinated vesicles had a 
hydrophobic selectivity of 2.33 compared to 3.06 for the CTAB/SOS vesicles.  The 
lower value signifies that the CTAB/FC7 vesicles are more polar than the CTAB/SOS 
vesicles.  Also, the fluorinated vesicles cannot separate a homologous series of 
compounds as well as the nonfluorinated vesicles can.  Figure 3.2 shows the 
electropherograms of a homologous series of alkylphenones using CTAB/FC7 and 
CTAB/SOS vesicles.  The resolution of the alkylphenones is much greater using the 
CTAB/SOS vesicles compared to the CTAB/FC7 vesicles. 
 
3.3.7 Efficiency Comparison 
The efficiency of CTAB/FC7 and CTAB/SOS vesicles using propiophenone and 
heptanophenone as test compounds is presented in Table 3.4.  The efficiency using 
CTAB/SOS vesicles was almost two times and five times higher than the efficiency 
using CTAB/FC7 vesicles for propiophenone and heptanophenone, respectively.  This 
significant difference in efficiency values could be caused by the mixed structures of 
the CTAB/FC7 aggregates.  The fluorinated aggregates are not only in  
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Figure 3.2.  Comparison of a homologous series of alkylphenones from acetophenone 
to heptanophenone using (A) CTAB/FC7 vesicles and (B) CTAB/SOS vesicles.  The 
buffer for both types of vesicles was 10 mM HEPES at pH 7.2.  Separation 
conditions:  A new fused silica capillary of 31.2 cm total length, 20.0 cm length to the 
detector, 50 µm ID, and 363 µm OD at 25°C was used for each vesicle system.  An 
applied voltage of 16 kV was used for the CTAB/FC7 vesicles while 14 kV was used 
for the CTAB/SOS vesicles.  Injection was done hydrodynamically for 2.0 s at 13.8 
mbar (0.2 psi).  Detection was done using PDA at 246 nm.   
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Table 3.4. Comparison of Methylene Selectivity and Efficiency Using CTAB/FC7 and 
CTAB/SOS vesicles. 
Vesicle Systema)
Methylene 
Selectivity 
αCH2
 
Efficiencya) 
N/m 
Efficiencyb) 
N/m 
CTAB/FC7 2.33 ± 0.14 44,000 3,000 
CTAB/SOS 3.06 ± 0.003 82,000 14,000 
a) Values represent the average of a minimum of 4 results for propiophenone. 
b) Values represent the average of a minimum of 4 results for heptanophenone. 
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the shape of spheres, but also the shapes of cylinders and flat disks [22].  These other 
shapes may contribute to slower mass transfer, which caused the peaks to be broader. 
 
3.3.8  LFER Analysis 
The fluorinated vesicles were also investigated through LFER analysis.  The results of 
LFER analysis for 3 batches of CTAB/FC7 vesicles are presented in Table 3.5 along 
with the LFER coefficients for CTAB/SOS vesicles, CTAB micelles, and lithium 
perfluorooctanesulfonate (LPFOS) micelles for comparison purposes.  LFER analysis 
using Abraham’s model of solvation [23] was employed for these calculations.  The 
following equation was used: 
log k = c + vV + eE + sS + aA + bB     (3.1) 
where k is the retention factor, V, E, S, A, and B are the solute descriptors, c is the y-
intercept, and v, e, s, a,  and b are the system coefficients.  The solute descriptors for 
the 26 compounds that were analyzed were presented in Table 2.5.  After a 
combination of residual analysis and root mean square error of cross-validation 
(RMSECV) analysis, it was determined that m-nitroaniline and butylbenzene were 
outliers.  These two solutes were removed from the set used to determine the LFER 
coefficients.  The cross-correlation table of the remaining 24 compounds is given in 
Table 3.6. 
 
The largest two system coefficients for the fluorinated vesicles were v and b, which 
were also the largest for the unfluorinated CTAB/SOS vesicles.  The values for v were 
all positive, indicating that it was easier to form a cavity for the solutes in the 
pseudostationary phase than in the BGE.  The range of v values for the CTAB/FC7 
vesicles was from 2.58 to 2.88.  This range of values was smaller than the v 
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Table 3.5. LFER coefficients for CTAB/FC7 vesicles, CTAB/SOS vesicles, CTAB 
micelles, and LPFOS micelles.a) 
 
Surfactant 
System v e s a b c n r
2 SE F 
CTAB/FC7 
vesicles 
(batch 1) 
2.58 
(0.06) 
0.32 
(0.04) 
-0.73 
(0.05)
-0.15 
(0.04)
-2.61 
(0.07)
-1.62 
(0.05) 24 0.982 0.07 989 
CTAB/FC7 
vesicles 
(batch 2) 
2.88 
(0.07) 
0.33 
(0.04) 
-0.86 
(0.06)
-0.15 
(0.05)
-2.88 
(0.08)
-1.74 
(0.05) 24 0.981 0.08 950 
CTAB/FC7 
vesicles 
(batch 3) 
2.86 
(0.08) 
0.26 
(0.05) 
-0.84 
(0.07)
-0.20 
(0.06)
-2.82 
(0.10)
-1.75 
(0.06) 24 0.974 0.10 681 
CTAB/SOS 
Vesicles 
3.32 
(0.07) 
0.59 
(0.04) 
-0.71 
(0.05)
0.84 
(0.05)
-3.78 
(0.08)
-1.72 
(0.05) 23 0.987 0.07 1343
CTAB 
micellesb)
2.71 
(0.05) 
1.11 
(0.09) 
-0.76 
(0.05)
0.82 
(0.04)
-2.44 
(0.06)
-1.83 
(0.06) 49 0.988 0.08 690 
LPFOS 
micellesb)
1.97 
(0.10) 
-0.11 
(0.13) 
-0.24 
(0.10)
-0.88 
(0.08)
-0.46 
(0.11)
-1.41 
(0.09) 62 0.941 0.19 180 
a) Values in parentheses represent standard deviations. 
b) Values obtained from Reference [24].  
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Table 3.6. Cross correlation table of solutes used for LFER Analysis of the 
CTAB/FC7 vesicles. 
 
 V E S A B 
V 1.000     
E 0.332 1.000    
S 0.301 0.217 1.000   
A 0.088 0.002 0.000 1.000  
B 0.150 0.028 0.372 0.038 1.000 
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coefficient for the CTAB/SOS vesicles, which was 3.32.  The larger v coefficient of 
the CTAB/SOS vesicles appears to be linked to the higher hydrophobic selectivity 
that was observed for these vesicles compared to the CTAB/FC7 vesicles. 
 
The range of values for the b coefficient using the CTAB/FC7 vesicles was from -2.88 
to -2.61.  The negative sign signifies that the PSP (vesicles) participates less in 
hydrogen bond acidity interactions than the BGE.  Since the BGE is mainly water, 
this value is appropriate for the systems investigated.   
 
For the e coefficient, the range of values using the CTAB/FC7 vesicles was from 0.26 
to 0.33.  The positive values indicate that capacity of the aggregate phase to interact 
with the solutes’ n- or π- electrons is higher than that of the BGE. These values were 
slightly higher than half the value of e obtained for the CTAB/SOS vesicles, which 
was 0.59.  The reason for the difference is most likely caused by the presence of the 
fluorinated surfactant in the CTAB/FC7 vesicles.  It has been reported that the e 
coefficient for systems with fluorocarbons is usually negative [25].  This is supported 
by the data of the LPFOS micelles.  While this is not the case here, the values of e are 
drastically smaller than those of the nonfluorinated vesicles. 
 
The values for the s coefficient were all negative which means the 
dipolarity/polarizability of the BGE is larger than that of the vesicle phase.  Again, 
this is reasonable since water comprises most of the BGE and water is a polar 
substance.  The vesicles are composed of surfactant molecules with both polar and 
nonpolar domains, which is why they have less ability to participate in 
dipolarity/polarizability interactions.  The range of s values for the CTAB/FC7 
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vesicles was from -0.86 to -0.73 while the s value for the CTAB/SOS vesicles was      
-0.71.  The magnitude of s is greater for the CTAB/FC7 vesicles because its 
fluorinated surfactant is more hydrophobic than the hydrogenated surfactants of the 
CTAB/SOS vesicles [18].   
 
Finally, the range of values for the a coefficient using CTAB/FC7 vesicles was from   
-0.20 to -0.15 while the value for the a coefficient using CTAB/SOS was 0.84.  Here 
the two different vesicle systems have the opposite sign.  This means that the 
CTAB/FC7 vesicles participate less in hydrogen bond basicity interactions, but the 
CTAB/SOS vesicles participate more in hydrogen bond basicity interactions.  The 
positive coefficient of the vesicles containing trimethylalkylammonium systems has 
been previously observed by Poole et al. [26].   
 
Another technique for interpreting the LFER coefficients is to normalize the values 
and then calculate the d value between the different combinations of vesicle systems.  
Table 3.7 shows the normalized values of the LFER coefficients using CTAB/FC7 and 
CTAB/SOS vesicles, as well as CTAB micelles and LPFOS micelles.  A survey of the 
normalized coefficients shows that generally, the values for the CTAB/FC7 are 
clustered together.  The true significance of the normalized LFER coefficients is the 
ability to use them to calculate values for the d parameter. 
 
The values for d using the normalized LFER coefficients for both CTAB/FC7 and 
CTAB/SOS are presented in Table 3.8.  First, the d values calculated between the 
three batches of CTAB/FC7 reveal values of 0.02, 0.03, and 0.02.  All of these values 
are less than 0.25, indicating that all 3 batches are chemically similar to each other as  
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Table 3.7. Normalized LFER coefficients for CTAB/FC7 vesicles, CTAB/SOS 
vesicles, CTAB micelles, and LPFOS micelles. 
 
Surfactant System vu eu su au bu
CTAB/FC7 
vesicles 
(batch 1) 
0.69 
(0.02) 
0.08 
(0.01) 
-0.19 
(0.01) 
-0.04 
(0.01) 
-0.70 
(0.02) 
CTAB/FC7 
vesicles 
(batch 2) 
0.69 
(0.02) 
0.08 
(0.01) 
-0.21 
(0.01) 
-0.04 
(0.01) 
-0.69 
(0.02) 
CTAB/FC7 
vesicles 
(batch 3) 
0.69 
(0.03) 
0.06 
(0.01) 
-0.20 
(0.02) 
-0.05 
(0.01) 
-0.69 
(0.03) 
CTAB/SOS 
Vesicles 
0.64 
(0.02) 
0.11 
(0.01) 
-0.14 
(0.01) 
0.16 
(0.01) 
-0.73 
(0.02) 
CTAB 
Micelles 
0.68 
(0.02) 
0.28 
(0.02) 
-0.19 
(0.01) 
0.21 
(0.01) 
-0.61 
(0.02) 
LPFOS 
Micelles 
0.89 
(0.06) 
-0.05 
(0.06) 
-0.11 
(0.04) 
-0.40 
(0.04) 
-0.21 
(0.05) 
a) Values in parentheses represent standard deviations. 
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Table 3.8. Calculated d values between surfactant systems. 
 
Surfactant 
System  1 2 3 4 5 6 
CTAB/FC7 
vesicles 
(batch 1) 
1 0      
CTAB/FC7 
vesicles 
(batch 2) 
2 0.02 0     
CTAB/FC7 
vesicles 
(batch 3) 
3 0.03 0.02 0    
CTAB/SOS 
vesicles 4 0.22 0.22 0.24 0   
CTAB 
 micelles 5 0.33 0.33 0.34 0.22 0  
LPFOS 
 micelles 6 0.66 0.65 0.64 0.82 0.83 0 
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was expected.  Next, the d values calculated between the CTAB/FC7 vesicles and the 
CTAB/SOS vesicles were 0.22, 0.22, and 0.24, with an average of 0.23.  Since the 
mean value of d is lower than 0.25, the fluorinated vesicles and the unfluorinated 
vesicles can be considered chemically similar to each other.  A comparison of the 
CTAB/FC7 vesicles to the CTAB micelles gave d values of 0.33, 0.33, and 0.34.  All 
of the values are greater than 0.25, so all of the CTAB/FC7 vesicle batches can be 
considered chemically different than the CTAB micelles.  The CTAB/FC7 vesicles 
can also be considered chemically different from the LPFOS micelles since the d 
values were 0.66, 0.65, and 0.64.  The CTAB/SOS vesicles were not chemically 
different from the CTAB micelles according to the d value of 0.22.  In contrast, the 
CTAB/SOS vesicles and the CTAB micelles were chemically different from the 
LPFOS micelles according to the respective d values of 0.82 and 0.83. 
 
3.4 Concluding Remarks 
Overall, the CTAB/FC7 vesicles were smaller and scattered less light than the 
CTAB/SOS vesicles.  However, the CTAB/FC7 vesicles proved to be more difficult to 
work with compared to the CTAB/SOS vesicles.  Despite their smaller size, the data 
collected at short wavelengths such as 214 nm contained more variation in the 
baseline.  The baseline disturbances made it difficult to identify the peaks.  In 
addition, smaller numbers of compounds could be present in the same sample when 
using the CTAB/FC7 vesicles due to the smaller elution range and therefore decreased 
resolution.   
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Chapter 4:  Electrokinetic Chromatography Using Surfactant Vesicles as a 
Predictor for Intestinal Permeability 
 
4.1 Introduction 
Drug discovery is a time and money-consuming endeavor.  In 2004 the cost to bring a 
new drug to market was reported as high as $0.8 to 1.7 billion [1].  Not only must the 
potential candidates be nontoxic and effective, but they must also be able to permeate 
the intestine in the case of an orally administered drug.  The ability to reach the 
desired target is a key aspect of the success of a new drug.  Therefore, the ability to 
rapidly screen the potential drug candidates for intestinal permeability is vital to 
determine whether they should be pursued or dismissed.  With this in mind, the 
pharmaceutical industry is always looking for fast, easy, accurate techniques for 
screening compounds.   
 
4.1.1 Background of Intestinal Permeability 
Intestinal permeability is an extremely complex process.  Figure 4.1 shows 5 different 
pathways for intestinal absorption.  For the drug to enter through passive absorption, 
it must go through the cell membrane of the enterocytes, (cells lining the intestine) or 
between two enterocytes [2].  Active transport and facilitated diffusion are two more 
ways for the drug to enter through the intestinal membrane.  Another path is when the 
drug is carried through the cell membrane by a transporter.  The drug could be 
metabolized and then both the drug and its metabolites would be absorbed.  Yet 
another method is via transport by a vesicle. Since there are such a large number of 
possible pathways to transverse the intestinal lining, it is not surprising that a single 
accurate model has not emerged [2]. 
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Figure 4.1.  Different pathways for intestinal absorption. 1) passive transcellular path; 
2) passive paracellular path; 3) carrier assisted path 4) carrier-mediated flux path; and 
5) vesicle transport path [3]. 
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4.1.1.1    Models to Predict Cell Membrane Permeability 
There are several different models that have been used to predict cell membrane 
permeability, including parallel artificial membrane permeability assay (PAMPA), 
cell-based systems, for example Caco-2 and Mardin-Darby canine kidney (MDCK) 
cells, liquid chromatographic methods using immobilized artificial membrane (IAM) 
columns, in silico methods, and vesicle and liposome electrokinetic chromatography.  
The two most widely used methods in the pharmaceutical industry are PAMPA and 
Caco-2 cells [2]. The aforementioned methods complement each other.  Typically, a 
high throughput method will not be as accurate as a more predictive method.  This is 
the reason multiple methods are used simultaneously. 
 
PAMPA, which was developed by Kansy et al. in 1998, is a high throughput intestinal 
permeability predictor method [4].  Thousands of compounds can be screened per 
week using this low-cost, easy and rapid assay [2].  Figure 4.2 shows the steps of the 
method.  Each well of a 96-well microtiter plate is filled with buffer.  Then the 
microtiter plate is covered with a microtiter filter plate, which has a hydrophobic filter 
material as a support.  Half of the wells of the microtiter filter plate are impregnated 
with lecithin in an organic solvent, such as dodecane.  The other wells are used as a 
reference and contain methanol/buffer solution.  UV measurements are taken to 
determine the concentration of the drug in each well [4].  A limitation of PAMPA is 
that it only models passive transport.  Consequently, it underestimates the absorption 
of actively transported drugs [2]. 
 
Caco-2 cells are from human colon adenocarcinoma and they are the most popular 
cell line for predicting intestinal permeability.  These cells are grown in monolayers 
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Figure 4.2.  PAMPA schematic showing the steps of the method.  The microtiter plate 
is placed on the buffer-filled 96-well plate.  Then half of the wells are impregnated 
with lecithin phospholipids.  Finally, the sample and reference wells are measured by 
UV analysis [4]. 
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on a porous membrane support and are very similar to the human intestinal 
epithelium.  Labor and cost of the method are two of its drawbacks.  The cost of 
analysis of one sample by Caco-2 is approximately $20.00 [5].  In addition, like 
PAMPA, it is a passive model for intestinal absorption and can give negative results 
for compounds that are easily transferred across the intestinal membrane [6].   
 
There have also been chromatographic-based permeability predictor models.  
Detroyer, et al. described a fast monolithic micellar liquid chromatography system to 
determine drug permeability [7].  They concluded that their predictions were best for 
compounds that were highly absorbed, meaning it was not a universally applicable 
technique.  Pascoe et al. reported using vesicle electrokinetic chromatography 
(VEKC) as an intestinal permeability model [8].  Their results showed good 
correlations between the logarithm of the retention factor values and the logarithm of 
Caco-2 intestinal permeability values.  Another example of EKC analysis, but with 
liposomes, instead of vesicles, was provided by Wang et al. [9].  In this study, the 
researchers correlated the logarithm of the retention factors measured for the 
pharmaceutical compounds to the drug oral fraction absorbed (Fa).  They observed a 
sigmoidal relationship between the two factors and suggested that their method 
needed to be improved by increasing the number of drugs studied and having equal 
numbers of low, medium, and high percent absorption values [9]. 
 
Given the promising results from other researchers, this work further pursues the 
potential of using unilamellar surfactant vesicles as a predictor for intestinal 
permeability.  The unilamellar surfactant vesicles are similar to the brush border 
membrane vesicles of the small intestine.  The intestinal membrane is highly 
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negatively charged, with one report estimating 1000-2000 negative charges/vesicle in 
the intestinal membrane [10].  The approach is to measure the retention factors of the 
pharmaceutical compounds using a vesicle PSP, and then to correlate the retention 
data to both Caco-2 permeability and intestinal permeability, using a logarithmic scale 
to space the data more evenly for purposes of both regression and visual presentation.  
Two types of vesicles were used in this work:  cetyltrimethylammonium bromide 
(CTAB)/sodium n-octyl sulfate (SOS) vesicles and cetyltrimethylammonium chloride 
(CTAC)/SOS vesicles.  The retention factors obtained were also correlated with 
octanol/water partition coefficients to compare the vesicles to others that have been 
previously reported. 
 
4.2 Materials and Methods 
4.2.1 Chemicals and Reagents 
CTAB, CTAC, N-(2-Hydroxyethyl)piperazine-N′-(2-ethanesulfonic acid) (HEPES), 
acebutolol hydrochloride, alprenolol, atenolol, caffeine, chloramphenicol, 
hydrocortisone, indomethacin, metoprolol tartrate, nadolol, oxprenolol hydrochloride, 
pindolol, progesterone, promethazine, propranolol hydrochloride, terbutaline 
hemisulfate, verapamil hydrochloride, and warfarin were obtained from Sigma-
Aldrich (St. Louis, MO, USA).  Ibuprofen was obtained from Acros (Morris Plains, 
New Jersey, USA).  SOS was purchased from Alfa Aesar (Ward Hill, MA, USA).  
HPLC grade methanol was purchased from Fisher (Pittsburgh, PA, USA).  Water 
from a Barnstead Nanopure Water system (Dubuque, IA, USA) was used to prepare 
the buffer. 
 114
4.2.2 Instrumentation 
A Beckman Coulter P/ACE™ MDQ Series Capillary Electrophoresis System 
(Fullerton, CA, USA) was used to perform the experiments.  A diode array detector 
was used to collect wavelengths of 200, 236, and 246 nm.  The thermostatted 
capillary cartridge and sample and buffer compartments were set at 25°C.  Joule 
heating was kept to 1.5 W/m or less by using an applied voltage of 14 kV for all 
separations.  The samples were injected for 4 seconds at 13.8 mbar (0.2 psi) 
corresponding to a volume of 3 nL.  The data was collected and processed using 32 
Karat™ Software Version 5.0. 
 
A new 31.2 cm x 50 µm ID fused silica capillary from Polymicro Technologies 
(Phoenix, AZ, USA) was used for each different preparation of vesicles.  Before 
every first use, each capillary was conditioned with 5 min of HPLC-grade water, 10 
min of 1.0 M sodium hydroxide, 5 min of 0.1 M sodium hydroxide, 3 min of HPLC-
grade water, and 15 min of background electrolyte (BGE) all at an applied pressure of 
2070 mbar (30 psi).  Between each injection the capillary was rinsed with 0.1 M 
NaOH for 1 min, HPLC-grade water for 2 min, and BGE for 1.5 min all at 2070 mbar.  
Then 15 kV was applied between the inlet and outlet buffer vials for 1.5 min. 
 
4.2.3 Vesicle Preparation 
The vesicles were prepared in a 1:3.66 mole ratio of CTAB:SOS or CTAC:SOS, 
giving a final total surfactant concentration of 69 mM.  The solid CTAB was weighed 
and then transferred to a 100 mL beaker using a small amount of water and stock 
HEPES buffer to make the final concentration of buffer 10 mM.  The HEPES buffer 
was adjusted to pH 7.2 by addition of 1.0 M LiOH.  At first the solution was cloudy 
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white, but after stirring and heating on a setting of 2, it became clear and colorless.  
As soon as all of the CTAB dissolved, the heat was turned off.  While the solution 
was still warm, solid white SOS was added to the beaker along with additional water.  
The solution had a bluish tinge to it after all of the solid SOS dissolved.  The solution 
was transferred to an appropriately sized volumetric flask and diluted to the mark with 
water.  Then the solution was vortex mixed for approximately 2 min.  The vesicles 
were not used until at least 12 hours had passed to allow the vesicles to equilibrate.  
The equilibration time was previously determined [11].  This same procedure was 
used to prepare the CTAC/SOS vesicles.  Prior to use, the vesicles were filtered using 
13 mm GD/X disposable nylon membrane filters with 0.45 µm pore size from 
Whatman (Sanford, ME, USA).  In addition, the vesicles were sonicated for 15 
minutes in a Branson Model 1510 Ultrasonic Cleaner purchased from Branson 
Ultrasonic Corporation (Danbury, CT, USA). 
 
4.2.4 Sample Preparation 
The pharmaceutical compounds were prepared at concentrations of 0.3-0.8 mg/mL.  
First, the appropriate amount of solid was weighed.  Then methanol was added to 
each sample followed by 10 mM HEPES so that the final ratio of methanol to HEPES 
was 6:4. 
 
4.2.5 Calculations   
The calculations for voltage-ramp corrected migration time, electroosmotic mobility 
(EOF), and retention factor can be found in Chapter 2.   The electrophoretic mobility 
of the analyte is calculated by the following equation: 
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where µep,CZE is the electrophoretic mobility of the analyte measured under CZE 
conditions and is equal to µnet - µeo.  µnet is calculated based upon Eq. (2.2) with the 
migration time of the analyte (tR) substituted for t0.  tP,CZE is the time it takes for a 
plug of acetone to reach the detector via pressure driven flow under CZE conditions.  
tP,VEKC is the time it takes for a plug of acetone to reach the detector via pressure 
driven flow under VEKC conditions.  In these experiments, the applied pressure was 
0.7 psi.  The electrophoretic mobility must be estimated because the migration time of 
the analyte is influenced by both chromatographic partitioning with the vesicles and 
its own electrophoretic mobility for charged analytes [12].   
 
A homologous series of alkylphenones (acetophenone through valerophenone) were 
analyzed and their retention factors calculated in order to determine tves, using the 
method of Bushey and Jorgenson [13] in which the logarithm of the retention factor 
vs. carbon number of a homologous series is assumed to yield a linear relationship.  
The retention time of valerophenone is used as a starting value for tves.  Then multiple 
iterations are performed to maximize r2 to determine tves [11]. 
 
4.3 Results and Discussion 
4.3.1 Correlation of VEKC to Caco-2 Permeability Using CTAB/SOS and 
CTAC/SOS Vesicles 
 
Table 4.1 shows the 22 pharmaceutical compounds that were investigated along with 
their pKa value, their average charge at pH 7.2, corresponding Caco-2 and intestinal 
permeability value, and logarithm P value.  The chemical structures of the 
pharmaceutical compounds are provided in Figure 4.3.  
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Table 4.1  Pharmaceutical compounds with pKa, average charge at pH 7.2, Caco-2 
permeability, intestinal permeability, and octanol-water partition coefficient. 
 
ID 
# Compound pKa
a)
Average 
 Charge 
at pH 7.2 
Caco-2b)
(10-6 
cm/s) 
Pintc)
(10-6 
cm/s) log Powd)
1 Ketoprofen 4.23 -1 23.15 5.19 -0.25 
2 Naproxen 4.84 -1 39.50 9.40 0.28 
3 salicylic acid 3.01 -1 22.00 9.24 2.26 
4 acetyl salicylic acid 3.48 -1 9.09 1.94 1.19 
5 Ibuprofen 4.41 -1 52.50 18.10 3.50 
6 Indomethacin 3.96 -1 20.40 6.94 4.27 
7 Warfarin 4.50 -1 21.10 2.47 2.70 
8 Caffeine 0.73 0 30.80 2.58 -0.07 
9 Hydrocortisone 12.47 0 14.00 6.61 1.61 
10 Chloramphenicol 11.03 0 20.60 12.09 1.14 
11 Progesterone 9.33 0 23.70 22.65 3.87 
12 Terbutaline 9.10 +1 0.47 2.95 0.48 
13 Acebutolol 9.16 +1 4.46 3.13 1.71 
14 Atenolol 9.17 +1 0.53 0.64 0.16 
15 Oxprenolol 9.17 +1 65.50 14.65 2.10 
16 Nadolol 9.14 +1 3.88 0.33 0.71 
17 Propranolol 9.20 +1 21.80 24.05 2.98 
18 Pindolol 9.17 +1 16.70 18.29 1.75 
19 Metoprolol 9.16 +1 23.70 5.06 1.88 
20 Alprenolol 8.98 +1 25.30 21.77 3.10 
21 Promethazine 8.97 +1 
not 
available 24.58 4.81 
22 Verapamil 9.33 +1 26.30 12.96 3.79 
a) pKa data from [14]. 
b) Caco-2 data from [15-20] 
c) Pint data from [21]. 
d) log Pow from [22, 23]. 
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Figure 4.3.  Chemical structures of the pharmaceutical compounds investigated. 
 
 
 119
 
 
 
 
 
 
 
O
CH3
O
CH3
N
CH3
CH3
CH3
N
O
CH3
O
CH3            
N
O
O
NH
OH
OH
O
Cl
Cl
 
Verapamil                                                                 Chloramphenicol 
 
OH
OH
O
OH
CH3
O
CH3
                       
N
O
CH3
O Cl
OH
CH3
O
 
Hydrocortisone                Indomethacin 
 
 
CH3
O
CH3
O
CH3
                          O O
OH O
CH3
 
Progesterone                                                                  Warfarin 
 
Figure 4.3.  (continued).  Chemical structures of the pharmaceutical compounds 
investigated. 
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Representative electropherograms are presented in Figure 4.4 using CTAB/SOS 
vesicles and Figure 4.5 using CTAC/SOS vesicles.  Also, the Caco-2 permeability 
was unavailable for promethazine so that compound was not included in the Caco-2 
correlations. 
 
4.3.1.1 Correlations Using Cationic Compounds 
The pharmaceutical compounds were separated by charge class (cations, neutrals, 
anions) before their retention factors were correlated to the logarithm of the Caco-2 
permeabilities (log PCaco-2).  Figure 4.6 shows the correlation of log PCaco-2 with the 
logarithm of the retention factors of the cationic pharmaceutical compounds using 
CTAB/SOS vesicles (log kCTAB/SOS,cations).  Nonlinear regression analysis using a four-
parameter dose-response curve was performed using GraphPad Prism version 5.01 for 
Windows,(GraphPad Software, San Diego, California, USA).  The general equation 
of the line used to fit the data is as follows: 
   ( ) )*50log(101 HillSlopeXEC
BottomTopBottomY −+
−+=   (4.2) 
where Bottom and Top are the lower and upper plateaus of the sigmoidal curve, 
respectively, EC50 is the X value that gives a response halfway between the Top and 
the Bottom or the inflection point, and HillSlope is the steepness of the curve [24].  
The parameters of the best fit line are shown in Table 4.2.  Figure 4.7 shows how 
similar the results are using CTAC/SOS vesicles to correlate log PCaco-2 with the 
logarithm of the retention factors of the cationic pharmaceutical compounds (log 
kCTAC/SOS,cations).  The parameters of the best fit line are shown in Table 4.2.  Sigmoidal 
relationships have previously been observed by Wang et al. [9] who correlated the 
logarithm of the retention factor using liposomes to the logarithm of the human 
fraction absorbed (Fa). 
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Figure 4.4.  Electropherograms showing separation of pharmaceutical compounds 
using CTAB/SOS vesicles with 10 mM HEPES buffer pH 7.2.  Compound 
identification according to Table 4.1.  Separation conditions:  A new fused silica 
capillary of 31.2 cm total length, 20.0 cm length to the detector, 50 µm ID, and 363 
µm OD at 25°C was used.  An applied voltage of 14 kV was used and injection was 
done hydrodynamically for 4.0 s at 13.8 mbar (0.2 psi).  Detection was done using 
PDA at 236 nm. 
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Figure 4.5.  Electropherograms showing separation of pharmaceutical compounds 
using CTAC/SOS vesicles with 10 mM HEPES buffer pH 7.2.  Compound 
identification according to Table 4.1.  Separation conditions as in Figure 4.4. 
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Figure 4.6.  Correlation of the Caco-2 permeabilities of the cationic compounds of 
Table 4.1 with their EKC retention factors using CTAB/SOS vesicles.  The average 
relative standard deviation (RSD) in log k was 7.9 %, with a range of 1.6 % to 19.4 
%.  Composition of vesicle solution:  1:3.66 mole ratio of CTAB:SOS, 69 mM total 
concentration, in 10 mM HEPES buffer (pH 7.2). 
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Figure 4.7.  Correlation of the Caco-2 permeabilities of the cationic compounds of 
Table 4.1 with their EKC retention factors using CTAC/SOS vesicles.  The average 
relative standard deviation (RSD) in log k was 5.9 %, with a range of 1.7 % to 20.3 
%.  Composition of vesicle solution:  1:3.66 mole ratio of CTAC:SOS, 69 mM total 
concentration, in 10 mM HEPES buffer (pH 7.2). 
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Table 4.2.  Parameters for the Nonlinear Regression Analysis of the Retention Factors 
Cationic Compounds Correlated with Caco-2 Permeabilities 
 
Vesicle 
System Top Bottom log(EC50) HillSlope R
2
CTAB/SOS 1.5 ± 0.1 -0.3 ± 0.3 -0.5 ± 0.1 2.7 ± 2.0 0.878 
CTAC/SOS 1.5 ± 0.2 -0.3 ± 0.4 -0.5 ± 0.2 2.2 ± 1.0  0.870 
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4.3.1.2 Correlations Using Neutral Compounds 
The graph of the correlation between the logarithm of the retention factors of the neutral 
compounds with the logarithm of the Caco-2 permeabilities using CTAB/SOS vesicles 
and CTAC/SOS vesicles are shown in Figures 4.8 and 4.9, respectively.  In both 
examples, the relationship is nonlinear with the four neutral compounds that were 
employed.  The data were fit with a quadratic, but this has not physical meaning.  The R2 
values of the fits were 0.731 and 0.733 using the CTAB/SOS vesicles and the CTAC/SOS 
vesicles, respectively.  It could be that the literature value of Caco-2 permeability for 
caffeine was incorrect.  Other values were used, but none of them were able to improve 
the relationship. 
4.3.1.3 Correlations Using Anionic Compounds 
The graphs of the correlations using anionic compounds for retention factors with 
logarithm of Caco-2 permeabilities are shown in Figures 4.10 and 4.11.  It can be 
observed that no apparent linear or sigmoidal trend was present.  This could be due to the 
fact that the retention factors of the anionic compounds were difficult to calculate.  One 
of the striking features of the graph is that the anionic compounds were clustered around 
the same location, whereas both the neutral and cationic compounds were more dispersed.  
There were difficulties in measuring the retention factors of the anionic compounds.  
Normally, the viscosity correction to determine the electrophoretic mobility of the analyte 
would be sufficient, but in these experiments, the retention factors of the anionic 
compounds were either very close to zero or negative, which does not make chemical 
sense.  Garcia et al. [14] indicated the increased amount of error associated with 
measuring retention factor for neutral compounds for which the migration time was 
similar to either t0 or tpsp.  An electrophoretic drag correction was considered for the 
vesicles, but this is also difficult to determine.  One possible reason for the difficulty in 
measuring the 
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Figure 4.8.  Correlation of the Caco-2 permeabilities of the neutral compounds of 
Table 4.1 with their EKC retention factors using CTAB/SOS vesicles.  The average 
relative standard deviation (RSD) in log k was 8.0 %, with a range of 5.2 % to 12.1 
%.  Conditions as in Figure 4.6. 
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Figure 4.9.  Correlation of the Caco-2 permeabilities of the neutral compounds of 
Table 4.1 with their EKC retention factors using CTAC/SOS vesicles.  The average 
relative standard deviation (RSD) in log k was 4.4 %, with a range of 0.92 % to 10.5 
%.  Conditions as in Figure 4.7. 
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Figure 4.10.  Correlation of the Caco-2 permeabilities of the anionic compounds of 
Table 4.1 with their EKC retention factors using CTAB/SOS vesicles.  The average 
relative standard deviation (RSD) in log k was 16.1 %, with a range of 0.65 % to 40.4 
%.  Conditions as in Figure 4.6. 
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Figure 4.11.  Correlation of the Caco-2 permeabilities of the anionic compounds of 
Table 4.1 with their EKC retention factors using CTAC/SOS vesicles.  The average 
relative standard deviation (RSD) in log k was 12.4 %, with a range of 2.6 % to 26.0 
%.  Conditions as in Figure 4.7. 
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retention factors of the anionic analytes was the electrostatic repulsions between the 
negatively charged analytes and the negatively charged vesicles.   
4.3.2 Correlation of VEKC to Intestinal Permeability Using CTAB/SOS and 
CTAC/SOS Vesicles 
 
4.3.2.1 Correlations Using Cationic Compounds 
The correlation of the logarithm of the intestinal permeabilities with the logarithm of 
the retention factor using CTAB/SOS vesicles is shown in Figure 4.12.  The data are 
extremely similar in profile to the correlations with Caco-2 permeability.  They are 
both well-fit by a sigmoidal function.  One major difference are the positions of 
nadolol and terbutaline.  These two compounds switch position going from 
correlations with Caco-2 to intestinal permeability.  Also, the data for the CTAC/SOS 
vesicles are similar to that of the CTAB/SOS vesicles.  The graph for the correlation 
of the cationic compounds using CTAC/SOS vesicles is given in Figure. 4.13.  The 
parameters for the sigmoidal lines are given in Table 4.3.   
4.3.2.2 Correlations Using Neutral Compounds 
For the neutral compounds, a linear relationship was observed for the correlations 
with the logarithm of retention factor with the logarithm of the intestinal 
permeabilities using both the CTAB/SOS vesicles and the CTAC/SOS vesicles.  
Figures 4.14 and 4.15 show the graphs using CTAB/SOS and CTAC/SOS, 
respectively.  The R2 value that was obtained was 0.924 for both types of vesicles and 
the slopes were statistically different from zero.  The R2 value reported here was 
higher than the R2 value of 0.727 obtained by Pascoe et al. [8] using CTAB/SOS 
vesicles for a set of 36 proprietary compounds.  This difference could be due to the 
fact that 36 compounds were included in the study reported by Pascoe et al. compared 
to the 4 neutral compounds reported here. 
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Figure 4.12.  Correlation of the intestinal permeabilities of the cationic compounds of 
Table 4.1 with their EKC retention factors using CTAB/SOS vesicles.  Conditions as 
in Figure 4.6. 
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Figure 4.13.  Correlation of the intestinal permeabilities of the cationic compounds of 
Table 4.1 with their EKC retention factors using CTAC/SOS vesicles.  Conditions as 
in Figure 4.7. 
 134
 
 
 
 
 
 
 
 
 
Table 4.3.  Parameters for the Nonlinear Regression Analysis of the Retention Factors 
Cationic Compounds Correlated with Intestinal Permeabilities 
 
Vesicle 
System Top Bottom log(EC50) HillSlope R
2
CTAB/SOS 1.3 ± 0.1 -0.17 ± 0.3 -0.33 ± 0.1 2.4 ± 1.6 0.865 
CTAC/SOS 1.3 ± 0.1 -0.08 ± 0.2 -0.24 ± 0.1 3.9 ± 3.7 0.868 
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Figure 4.14.  Correlation of the intestinal  permeabilities of the neutral compounds of 
Table 4.1 with their EKC retention factors using CTAB/SOS vesicles.  Conditions as 
in Figure 4.6. 
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Figure 4.15.  Correlation of the intestinal  permeabilities of the neutral compounds of 
Table 4.1 with their EKC retention factors using CTAC/SOS vesicles.  Conditions as 
in Figure 4.7. 
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4.3.2.3 Correlations Using Anionic Compounds 
No clear correlations of retention factor to intestinal permeabilities for the anionic 
compounds could be established using either the CTAB/SOS vesicles nor the 
CTAC/SOS vesicles.  Figure 4.16 shows the graph of log Pint vs. log k using 
CTAB/SOS vesicles.  The reason for the lack of correlation is also the same as those 
previously given in Section 4.3.1.3.  Figure 4.17 contains the graph of intestinal 
permeability vs. retention factor using CTAC/SOS vesicles. 
 
4.3.3 Correlation of VEKC Retention Factors with Octanol-Water Partition 
Coefficients using CTAB/SOS and CTAC/SOS Vesicles 
 
VEKC has been previously used to predict logarithm Pow for both pesticides[25] and 
pharmaceutical compounds [8, 26].  To show that the vesicles presented here were 
similar to those reported in the past, the retention factors obtained using CTAB/SOS 
vesicles were correlated to logarithm Pow values.   
 
4.3.3.1 Correlations Using Cationic Compounds 
The graphs of the correlations of logarithm Pow for the cationic compounds with the 
logarithm of the retention factor obtained using CTAB/SOS and CTAC/SOS vesicles 
can be found in Figures 4.18 and 4.19, respectively.  There is a linear relationship 
observed in both of these plots.  The R2 value using CTAB/SOS vesicles is 0.863 
compared to an R2 of 0.889 using the CTAC/SOS vesicles.  These values are very 
similar to the correlation coefficient of 0.879 reported by Razak et al. who also used 
CTAB/SOS vesicles [26], as well as the correlation coefficient of 0.850 reported by 
Pascoe et al. for CTAB/SOS vesicles [8].   
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Figure 4.16.  Correlation of the intestinal permeabilities of the anionic compounds of 
Table 4.1 with their EKC retention factors using CTAB/SOS vesicles.  Conditions as 
in Figure 4.6. 
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Figure 4.17.  Correlation of the intestinal permeabilities of the anionic compounds of 
Table 4.1 with their EKC retention factors using CTAC/SOS vesicles.  Conditions as 
in Figure 4.7. 
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Figure 4.18.  Correlation of the octanol-water partition coefficients of the cationic 
compounds of Table 4.1 with their EKC retention factors using CTAB/SOS vesicles.  
Conditions as in Figure 4.6. 
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Figure 4.19.  Correlation of the octanol-water partition coefficients of the cationic 
compounds of Table 4.1 with their EKC retention factors using CTAC/SOS vesicles.  
Conditions as in Figure 4.7. 
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4.3.3.2 Correlations Using Neutral Compounds 
Similar to the results correlating the logarithm of Pow for the cationic compounds, 
there is also a linear relationship using the neutral compounds.  Figure 4.20 shows the 
correlation of logarithm of Pow vs. the retention factors of the neutral compounds 
using CTAB/SOS vesicles.  Figure 4.21 has the equivalent graph using CTAC/SOS 
vesicles.  The R2 for both of the regression lines is 0.959, which is better than the R2 
values found for the cationic compounds.   
 
4.3.3.3 Correlations Using Anionic Compounds 
Finally, the correlation for the anionic compounds’ retention factors and the logarithm 
of Pow using CTAB/SOS vesicles is given in Figure 4.22.  The corresponding graph 
using CTAC/SOS vesicles is given in Figure 2.23.  Following the same trend as was 
observed for the correlations with Caco-2 and intestinal permeabilities, there was no 
clear relationship between log Pow and log k for the anionic compounds.  It is apparent 
that the charge of the compound plays a major role in the strength of the correlations 
from this data. 
 
4.4 Concluding Remarks 
The correlations with retention factor were better for intestinal permeabilities 
compared to correlations with Caco-2 permeabilities.  The results of all the 
correlations with the logarithm of the retention factor indicate that the correlations are 
better for neutral and positively charged analytes than for negatively charged ones.  
For this approach to succeed, the compounds should be run at a pH where they are 
neutral.  It would be ideal to have a method where all of the compounds could be run 
at the same pH to facilitate rapid analysis.  This does not  
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Figure 4.20.  Correlation of the octanol-water partition coefficients of the neutral 
compounds of Table 4.1 with their EKC retention factors using CTAB/SOS vesicles.  
Conditions as in Figure 4.6. 
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Figure 4.21.  Correlation of the octanol-water partition coefficients of the neutral 
compounds of Table 4.1 with their EKC retention factors using CTAC/SOS vesicles.  
Conditions as in Figure 4.7. 
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Figure 4.22.  Correlation of the octanol-water partition coefficients of the anionic 
compounds of Table 4.1 with their EKC retention factors using CTAB/SOS vesicles.  
Conditions as in Figure 4.6. 
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Figure 4.23.  Correlation of the octanol-water partition coefficients of the anionic 
compounds of Table 4.1 with their EKC retention factors using CTAC/SOS vesicles.  
Conditions as in Figure 4.7. 
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seem possible under the conditions described in this report.  Another alternative 
would be to use reversed mode CE with a positively charged vesicle and short end 
injection for analysis of the anionic compounds.  As for the correlations of logarithm 
k with logarithm Pow, a similar trend was observed regarding the anionic compounds.  
These compounds are related to logarithm Pow in a nonlinear fashion.  The correlation 
would most likely be linear if the compounds were analyzed under conditions where 
they would be neutral as demonstrated by Klotz et al. [25] for the correlation of 
organic acids to Pow at pH 2 using CTAB/SOS vesicles. 
 
One other interesting aspect of this investigation is that both CTAB/SOS vesicles and 
CTAC/SOS vesicles have provided similar results in the correlations.  This proves 
that not only CTAB/SOS vesicles are useful passive models of cell membranes, but 
CTAC/SOS vesicles are as well.  In order to improve the model, a larger number of 
compounds should be investigated at a pH in which they are neutral.  In addition, 
cholesterol could be added to these vesicles to possibly improve the correlations, 
although previous additions were by no means universally successful and increased 
the complexity of the PSP [8].  
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Chapter 5:  Conclusions and Recommendations for Future VEKC Experiments 
 
 
VEKC using synthetic vesicles formed from cationic and anionic surfactants has been 
investigated for the purpose of i) identifying the effect of cationic surfactant counterion; 
ii) improving the efficiency of highly hydrophobic compounds in order to facilitate the 
measurement of their retention factors; iii) developing smaller vesicles in order to reduce 
light scattering in the low UV in order to improve sensitivity; and iv) developing a high 
throughput method for estimating intestinal permeability.  The cationic surfactant 
counterion did not dramatically affect the chromatographic results, but it did provide 
interesting effects in terms of selectivity.  Next, the smaller vesicles that were developed 
(CTAB/FC7) were not as effective at improving sensitivity as originally hoped.  The 
results using the fluorinated vesicles contained noisy baselines and the sensitivities were 
worse compared to the CTAB/SOS vesicles.  In contrast, there were some promising 
results with respect to the correlations of retention factor with intestinal permeability for 
cationic and neutral analytes.  The method needs improvement however if it is to be 
employed by the pharmaceutical industry. 
 
One thing that could be done to improve the correlations of retention factor with 
intestinal permeability would be to use a pH where the compounds are neutral.  The 
effect of pH has been examined by Razak et al. in terms of correlations of retention factor 
with log Pow [1].  Another suggestion would be to add cholesterol to the vesicles to make 
them more similar to the epithelial cells of the intestine.   
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To further the development of VEKC, it would be useful to identify a reliable marker for 
the vesicles that could be added to each sample.  This in-situ monitoring of the time of 
the vesicle would be beneficial because any changes would be identified as they occur.  
The approach used for the experiments described here took an average µep,ves from 8 or 
less injections   While µep,ves is not expected to change drastically, there are some slight 
deviations from one injection to the next.  Additionally, if there were a large change in 
µep,ves, then that would be an indication of a larger problem.  Some suggestions for a 
marker for the vesicles would be dodecanophenone or octylbenzene [2].  Of course, 
adding a marker to every sample would increase the run times, which may be a 
disadvantage which would have to be weighed against the possible improvement caused 
by the accuracy of the marker. 
 
It would be interesting to see the effects of using other vesicles in EKC analyses.  Some 
suggestions for other vesicles to use would be those that are composed of double-tailed 
surfactants, such as didodecyldimethyl ammonium bromide (DDAB)/bis(2-ethylhexyl) 
sodium sulfosuccinate (AOT) vesicles [3].  A completely fluorinated vesicle may also be 
worthwhile to explore for different selectivity and improved efficiency.  Extreme care 
would need to be taken with the handling and disposal of any perfluorinated components, 
though.  A good source of other potential vesicles is the review by Segota and Tezak [4].  
Many different surfactant vesicles are available, as well as phospholipid vesicles.   
 
The area of chiral analysis using VEKC has been steadily growing over recent years [5, 
6].  Consequently, chiral vesicles would be another interesting research subject.  Only 
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one group has reported the successful creation and implementation of chiral vesicles in 
CE.  There is a great need for rapid chiral analysis.  Previously vesicles composed of 
CTAB and dodecoxycarbonylvaline (DDCV) with HEPES buffer showed no 
enantioselectivity [7].  Perhaps if the buffer were changed to sodium phosphate or 
another buffer that was not zwitterionic and/or bulky, then the vesicles would exhibit 
enantioselectivity.  If the lack of stereoselectivity is due to strong interactions of the 
oppositely-charged head groups, however, switching to a different type of buffer may not 
lead to an improvement.   
 
The variable of temperature has not been investigated with respect to VEKC analysis.  It 
would be interesting to see if temperature has any effect on the correlations with 
intestinal permeability.  Since internal body temperature is higher than room temperature 
(at which all of the VEKC experiments have been performed), the results may change for 
the better.   
 
Still another interesting experiment would be to use the vesicles in EKC using a laser 
induced fluorescence (LIF) detector.  These experiments could demonstrate the carrier 
properties of the vesicles if a fluorescently active compound were encapsulated within it.  
One possible drawback would be that the counterion of the vesicles could act as a 
fluorescence quencher, though.  Also, it might be interesting to compare the intensity of 
the fluorescence signal in the presence and absence of vesicles or use whole column 
detection with a charge coupled device (CCD) camera and a µTotal Analysis System 
(TAS). 
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One type of characterization that should be conducted on the vesicles is cryogenic 
transmission electron microscopy (cryo-TEM).  This would provide a more accurate 
image of the vesicles and would give a better idea of the true shape of the vesicles.  For 
the most part, the vesicles are probably spherical, but there could be other shapes present, 
which may influence the separations in VEKC analysis. 
 
A more comprehensive study should be conducted to resolve whether the results in 
VEKC are better when the samples are prepared in a mixture of buffer and organic 
solvent versus the vesicle solution.  In microemulsion electrokinetic chromatography 
(MEEKC), the samples are prepared in the microemulsion solution to avoid disrupting 
the microemulsion.  It could be that more reproducible results would be obtained by 
simply changing the diluent of the analytes to the vesicle solution. 
 
Overall, VEKC is a valuable mode of CE analysis with increased elution range and 
different selectivity compared to micellar electrokinetic chromatography (MEKC) and 
MEEKC.  VEKC has potential as a high throughput estimator of intestinal permeability 
and log Pow.  There are still several areas of VEKC that can be developed including a 
study to find a suitable marker to estimate the time of the vesicles, chiral analysis, and 
temperature analysis.  The future of VEKC is unlimited with respect to all of the vesicles 
that have not been tried, as well.  Since it is such a fast, inexpensive analysis technique, 
the breadth and number of VEKC applications should continue to increase. 
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Appendix A:  Correlations of Caco-2 and Intestinal Permeability with Retention 
Factors of Cationic and Neutral Compounds Combined 
 
 
A.1  Correlation of VEKC to Caco-2 Permeability Using CTAB/SOS Vesicles 
Since there was difficulty in measuring the retention factors of the anionic compounds, 
they were omitted from the correlation.  After residual analysis was completed for the 
remaining data, it was determined that atenolol, caffeine, oxprenolol, and terbutaline 
were outliers.  All of these compounds had residuals > 0.5.  The correlation of the 
logarithm of the Caco-2 permeabilities to the retention factors of the remaining neutral 
and cationic compounds is shown in Figure A.1.  The R2 value was 0.465 with a 95% 
confidence interval of 0.184 to 0.324, which does not include 0, indicating that the slope 
is statistically significant.   
 
A.2  Correlation of VEKC to Caco-2 Permeability Using CTAC/SOS Vesicles 
The correlation coefficient with the anionic compounds removed for the correlation of 
Caco-2 permeabilities to retention factors using CTAC/SOS vesicles was 0.456, which 
was slightly lower than the correlation coefficient obtained using the retention factors 
obtained with the CTAB/SOS vesicles.  See Figure A.2.  The 95% confidence interval of 
the slope was 0.384 to 0.523, which indicated that the value was statistically significant 
and not 0. 
 
A.3  Correlation of VEKC to Intestinal Permeability Using CTAB/SOS Vesicles 
For the following results, the data for nadolol was not used since its residual was > 0.5.  
In addition, there were difficulties determining the retention factors for ketoprofen and  
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Figure A.1.  Correlation of the Caco-2 permeabilities of the cationic and neutral compounds of Table 4.1 with their EKC retention 
factors using CTAB/SOS vesicles.  Compounds as in Table 4.1.  Composition of vesicle solution:  1:3.66 mole ratio of CTAB:SOS, 
69 mM total concentration, in 10 mM HEPES buffer (pH 7.2). 
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Figure A.2.  Correlation of the Caco-2 permeabilities of the cationic and neutral compounds of Table 4.1 with their EKC retention 
factors using CTAC/SOS vesicles.  Compounds as in Table 4.1.  Composition of vesicle solution:  1:3.66 mole ratio of CTAC:SOS, 
69 mM total concentration, in 10 mM HEPES buffer (pH 7.2). 
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salicylic acid so these compounds were also omitted.  The graph of the logarithm of 
intestinal permeability (Pint) versus the logarithm of the retention factor (k) using 
CTAB/SOS vesicles using all cationic, neutral, and anionic compounds is shown in 
Figure A.3.  The R2 value was 0.707, indicating a slight correlation.  Razak et al. had 
expressed concern about correlating the retention factors of anionic compounds to 
logarithm Pow using anionic vesicles [1] .  Figure A.4 shows the correlation of logarithm 
Pint versus logarithm k using CTAB/SOS vesicles excluding anionic compounds.  When 
the anionic compounds were excluded, the R2 value increased to 0.849.  This 
demonstrated that there were electrostatic interactions taking place between the anionic 
pharmaceutical compounds and the anionic vesicles that reduced the correlation between 
Pint and k for these compounds.  The R2 results of all of the replicates using CTAB/SOS 
vesicles for correlation of logarithm Pint to logarithm k are shown in Table A.1.  The 
correlations became slightly lower with time as shown by the progression from replicate 
1 to replicate 3.  When a fresh preparation of vesicles was used (replicate 4), the 
correlation returned to its previous level.  This could be caused by changes in vesicle 
morphology, such as aggregation of smaller vesicles to form larger ones.   
 
A.4  Correlation of VEKC to Intestinal Permeability Using CTAC/SOS Vesicles 
In order to examine any possible effects caused by the counterion of the cationic 
surfactant in the vesicles, the retention factors of the pharmaceutical compounds were 
also measured using CTAC/SOS vesicles.  For these results, the data for nadolol was 
omitted since its residual was > 0.5.  Similar to the CTAB/SOS vesicle results, there were 
difficulties determining the retention factors for ketoprofen, salicylic acid, and  
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Figure A.3.  Correlation of the intestinal permeabilities of a diverse set of cationic, neutral, and anionic pharmaceutical compounds 
with their corresponding retention factors obtained using electrokinetic chromatography (EKC) with CTAB/SOS vesicles as the 
pseudostationary phase  (PSP).  Compounds as in Table 4.1.  Composition of vesicle solution:  1:3.66 mole ratio of CTAB:SOS, 69 
mM total concentration, in 10 mM HEPES buffer (pH 7.2).   
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Figure A.4.  Correlation of the intestinal permeability of the cationic and neutral compounds of Table 4.1 with their EKC retention 
factors using CTAB/SOS vesicles.  Conditions as in Figure A.1.  
 
 
 162
 
 
 
 
 
 
 
Table A.1.  R2 values for replicate CTAB/SOS vesicle correlation of log Pint to log k. 
Replicate # R2 using all compounds R2 excluding anionic compounds 
1 0.707 a) 0.849 
2 0.640 a) 0.781 
3 0.607 a) 0.776 
4 0.676 a) 0.796 
a) Excluding ketoprofen and salicylic acid since the measured retention factors were 
     negative and excluding nadolol since it was an outlier. 
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acetylsalicylic acid so these compounds were also omitted.  The graph of the best 
correlation using all of the compounds in shown in Figure A.5.  The R2 value for this 
correlation was 0.625, which was slightly lower than the best correlation using the 
CTAB/SOS vesicles.  The graph with the best correlation excluding the anionic 
compounds for CTAC/SOS vesicles is shown in Figure A.6.  The R2 value for this 
correlation was 0.791, which falls in the middle of the range of the R2 values for the 
CTAB/SOS vesicles.  Table A.2 contains the R2 values for additional correlations using 
CTAC/SOS vesicles.  The correlations were lower than expected based upon the results 
reported by Pascoe et al. [2].  Using CTAB/SOS vesicles, they reported an R2 value of 
0.727.  However, one major difference between these results and the previous results is 
that the majority of compounds used by Pascoe et al. were neutral whereas 4 out of 21 
compounds were neutral in the present study.  The correlations seem to be heavily 
dependent upon the charge of the analytes under investigation.   
 
A.5  Correlation of VEKC to logarithm Pow using CTAB/SOS and CTAC/SOS 
Vesicles 
 
In order to determine the best fit of the data, the anionic compounds were omitted as 
outliers.  Figure A.7 shows the correlation of logarithm Pow vs. logarithm k for all of the 
neutral and cationic pharmaceutical compounds using CTAB/SOS vesicles.  The R2 value 
was 0.911.  The increase in correlation coefficient is probably due to the set of test 
compounds that was investigated and the removal of the anionic compounds.  The 
retention factors obtained using CTAC/SOS vesicles were also correlated to logarithm 
Pow data.  Again the anionic compounds were removed so a linear regression line could 
be calculated.  Figure A.8 shows the results of the graph of logarithm Pow vs. logarithm k
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Figure A.5.  Correlation of the intestinal permeabilities of a diverse set of cationic, neutral, and anionic pharmaceutical compounds 
with their corresponding retention factors obtained using electrokinetic chromatography (EKC) with CTAC/SOS vesicles as the 
pseudostationary phase  (PSP).  Compounds as in Table 4.1.  Conditions as in Figure A.2. 
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Figure A.6.  Correlation of the intestinal permeability of the cationic and neutral compounds of Table 4.1 with their EKC retention 
factors using CTAC/SOS vesicles.  Conditions as in Figure A.2. 
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Table A.2.  R2 values for replicate CTAC/SOS vesicle correlation of log Pint to log k. 
Replicate # R2 using all compounds R2 excluding anionic compounds 
1 0.625 a) 0.791 
2 0.570 a) 0.773 
3 0.599 a) 0.778 
a) Excluding ketoprofen, salicylic acid, and acetylsalicylic acid since the measured 
retention factors were negative and nadolol since it was an outlier. 
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Figure A.7.  Correlation of the octanol water partition coefficients of the cationic and neutral compounds of Table 4.1 with their EKC 
retention factors using CTAB/SOS vesicles.  Conditions as in Figure A.1. 
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igure A.8.  Correlation of the octanol water partition coefficients of the cationic and neutral compounds of Table 4.1 with their EKC F
retention factors using CTAC/SOS vesicles.  Conditions as in Figure A.2. 
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using CTAC/SOS vesicles for only the neutral and cationic compounds.  The correlation 
coefficient was 0.907, which is very similar to the result using CTAB/SOS vesicles. 
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Appendix B:  Attempts at Creating New Vesicles 
 
Several attempts were made at creating new vesicles from cetyltrimethylammonium 
bromide (CTAB) and sodium dodecyl sulfate (SDS).  However, all of these attempts 
resulted in the creation of micelles or unstable saturated solutions instead.  Table B.1 lists 
the components and concentrations of the vesicle attempts.  The motivation for creation 
of the vesicles was to create a system with common chemicals that most laboratories 
would have readily available. 
 
The appropriate amount of surfactant was mixed together in 10 mM phosphate buffer (pH 
7.2) and then the resulting solution was analyzed using a Horiba LB 500 Dynamic Light 
Scattering Particle Size Analyzer (Irvine, CA, USA).  If the solution was very cloudy, if 
precipitate was present, or if the solution contained multiple phases, then the size of the 
particles in solution was not measured. 
 
A few papers have described the combined use of CTAB and SDS as pseudostationary 
phases in electrokinetic chromatography [1, 2] and as capillary coatings [3], but the 
results described in the papers regarding CTAB/SDS vesicles [4-6] could not be 
replicated.  For example, the 5 mM CTAB and 20 mM SDS combination was chosen 
based upon the results reported by Ying et al. [6], while the 15 mM CTAB and 25 mM 
SDS combination was chosen based upon the results of Tomasic et al. [5].  The difficulty 
duplicating the other groups’ results could be related to the fact that unlike the literature 
sources, the solutions were prepared in 10 mM Phosphate buffer.  Another difference is  
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Table B.1.  Compositions of CTAB/SDS vesicle attempts. 
[CTAB] 
mM 
[SDS] 
mM 
Buffer Appearance Mean Diameter 
0.1 10 10 mM Phosphate Clear and colorless 0.004-0.005 µm 
5 20 10 mM Phosphate Milky white 2.5-3 µm 
15 25 10 mM Phosphate Milky white – 
10 40 10 mM Phosphate Milky white – 
0.1 0.6 10 mM Phosphate Slightly cloudy – 
0.1 1.5 10 mM Phosphate Slightly cloudy – 
0.1 0.3 10 mM Phosphate Slightly cloudy – 
0.1 10 No buffer Clear and colorless – 
0.1 1.5 No buffer Clear and colorless 0.004-0.006 µm 
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that the surfactants were used as received whereas some of the references stated that the 
surfactants were recrystallized before use [5].  No buffer was used for two of the vesicle 
attempts, but the resulting particle size of the components in solution was not indicative 
of the presence of vesicles.  If the experiments were to be repeated, then the surfactants 
should be purified to test whether that was the source of the discrepancy. 
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Appendix C:  List of Symbols 
 
 
a0.1  width of the first half of the peak at 10% peak height 
b0.1  width of the second half of the peak at 10% peak height 
αPG  polar group selectivity 
αCH2  methylene selectivity 
CH2 methylene group 
ε0  permittivity of a vacuum 
εr  relative permittivity of the buffer 
η  viscosity 
n  carbon number 
σ2  variance or standard deviation squared 
µeo  electroosmotic mobility 
µep  electrophoretic mobility 
µep,analyte electrophoretic mobility of the analyte 
µep,CZE electrophoretic mobility under capillary zone electrophoresis conditions 
µep,ves electrophoretic mobility of the vesicle 
µep,PSP  electrophoretic mobility of the pseudostationary phase 
µnet  net mobility 
µves  net mobility of the vesicle 
µr  relative electrophoretic mobility 
ζ  zeta potential 
ω  normalization parameter 
d  distance parameter 
E  electric field  
H  plate height 
k  retention factor 
k1  retention factor, peak #1 
k2  retention factor, peak #2 
kavg  average retention factor 
kb  retention factor of benzene 
ks  retention factor of a substituted benzene 
kmod  retention factor of the solute using 10% ACN modified vesicles 
kunmod  retention factor of the solute using unmodified vesicles 
L  length of the capillary 
Ld  length to the detector 
Ltot   total capillary length 
N  efficiency or number of theoretical plates 
Pint   intestinal permeability 
Pow  octanol water partition coefficient  
r2 the square of the correlation coefficient 
Rs  resolution 
t0  migration time of a neutral solute 
tmc  migration time of the micelle  
tves  migration time of the vesicle  
 176
tP,CZE migration time for a solute pressure plug under capillary zone 
electrophoresis conditions  
tP,VEKC migration time for a solute pressure plug under vesicle electrokinetic 
chromatography conditions 
tpsp  migration time of the pseudostationary phase 
tR  migration time of the solute 
tramp  time of the linear voltage-ramp 
tVRC  voltage ramp corrected migration time 
V  voltage 
W0.1  peak width at 10% peak height 
 
 
List of LFER Analysis Symbols 
 
 
V  McGowan’s characteristic volume 
E  excess molar refraction 
S  dipolarity/polarizability 
A  hydrogen bond acidity 
B  hydrogen bond basicity 
c   y-intercept 
v  difference in the ease of cavity formation for the solute between the 
 buffer and the aggregate phase (vesicles) 
e  difference in capacity of the buffer and the aggregate phase to interact 
 with the solutes’ n- or π- electrons 
s  difference in dipolarity/polarizability between the aggregate phase 
and the bulk aqueous phase 
a  difference in hydrogen bond basicity 
b  difference in hydrogen bond acidity 
vu  normalized v coefficient 
eu  normalized e coefficient 
su  normalized s coefficient 
au  normalized a coefficient 
bu  normalized b coefficient 
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Appendix D:  List of Abbreviations 
 
 
AB   2-amino-1-butanol 
ACN   acetonitrile 
AOT   bis(2-ethylhexyl)sodium sulfosuccinate 
BGE   background electrolyte 
CE   capillary electrophoresis 
CEC    capillary electrochromatography 
CGE    gel electrophoresis 
CIEF   capillary isoelectric focusing 
CITP    capillary isotachophoresis 
CMC   critical micelle concentration 
cryo-TEM   cryogenic transmission electron microscopy 
CTAB   cetyltrimethylammonium bromide 
CTAC   cetyltrimethylammonium chloride 
CZE   capillary zone electrophoresis 
DDAB   didodecyldimethyl ammonium bromide 
DDCV   dodecoxycarbonylvaline 
DMPC   dimyristoyl L-α-phosphatidylcholine  
DMPG   dimyristoyl L-α-phosphatidyl-D,L-glycerol 
DPPC   1,2-dipalmitoyl-sn-glycero-3-phosphocholine 
EKC   electrokinetic chromatography 
EOF   electroosmotic flow 
Eq.   equation 
ER   elution range 
Fa    fraction absorbed 
FASS    field-amplified sample stacking 
FC7   sodium perfluorooctanoate 
FSCE   free solution CE 
HEPES   N-(2-Hydroxyethyl)piperazine-N′-(2-ethanesulfonic acid) 
HPLC   high performance liquid chromatography 
IAM    immobilized artificial membrane 
i.d.   inner diameter 
IHP    inner Helmholtz plane 
ITP   isotachophoresis 
LFER    linear free energy relationship 
LIF   laser induced fluorescence 
MDCK   Mardin-Darby canine kidney 
MEEKC  microemulsion electrokinetic chromatography 
MEKC   micellar electrokinetic chromatography 
NaOH   sodium hydroxide 
MS   mass spectrometry 
OHP    outer Helmholtz plane 
OTAB   octyltrimethylammonium bromide 
PA   phosphatidic acid 
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PAMPA   parallel artificial membrane permeability assay 
PC   phosphatidylcholine  
PDA    photo diode array 
PE   1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine 
PG   phosphatidyl glycerol 
PI   phosphatidyl inositol 
POPC   1-palmitoyl-2-oleyl-sn-glycero-3-phosphocholine 
PS   phosphatidylserine 
PSP   pseudostationary phase 
SDLIL   sodium N-[4-n-dodecyloxybenzoyl]-L-isoleucinate 
SDLL   sodium N-[4-n-dodecyloxybenzoyl]-L-leucinate 
SDS   sodium dodecyl sulfate 
SOS   sodium n-octyl sulfate 
SPE   solid-phase extraction 
SPH   sphingomyelin 
SUVs    small unilamellar vesicles 
UV   ultraviolet  
VEKC   vesicle electrokinetic chromatography 
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